Unnamed: 0,title,date,stock,sentiment
623813.0,Hologic shares are trading higher after the company guided growth in its diagnostics segment.,2020-06-09 08:51:00-04:00,HOLX,positive
623814.0,"Morgan Stanley Maintains Equal-Weight on Hologic, Raises Price Target to $55",2020-06-09 08:02:00-04:00,HOLX,neutral
623815.0,"Hologic Inc Sees Q3 Diagnostics Revenue To Grow 20-25%, Sees Q3 Breast And Skeletal Health Revenue To Decline 30-35%, Sees Q3 Surgical Revenue To Decline 65-70%.",2020-06-08 16:43:00-04:00,HOLX,neutral
623816.0,"Benzinga's Top Upgrades, Downgrades For June 3, 2020",2020-06-03 09:33:00-04:00,HOLX,positive
623817.0,Hologic shares are trading higher after Raymond James upgraded the stock from Market Perform to Outperform and announced a price target of $62 per share.,2020-06-03 08:31:00-04:00,HOLX,positive
623818.0,"Raymond James Upgrades Hologic to Outperform, Announces $62 Price Target",2020-06-03 07:30:00-04:00,HOLX,neutral
623819.0,"Hologic Granted FDA Emergency Use Authorization For Its Second Molecular Test For COVID-19/Coronavirus; Co. Has Begun Distributing Its New Coronavirus Test, And Expects To Produce An Average Of 1M Tests Per Week",2020-05-15 08:02:00-04:00,HOLX,negative
623820.0,"UBS Maintains Neutral on Hologic, Raises Price Target to $56",2020-05-01 12:11:00-04:00,HOLX,neutral
623821.0,"Wells Fargo Maintains Overweight on Hologic, Raises Price Target to $60",2020-04-30 11:31:00-04:00,HOLX,negative
623822.0,"Morgan Stanley Maintains Equal-Weight on Hologic, Raises Price Target to $53",2020-04-30 08:47:00-04:00,HOLX,neutral
623823.0,10 Biggest Price Target Changes For Thursday,2020-04-30 08:11:00-04:00,HOLX,neutral
623824.0,Hologic shares are trading higher after the company reported better-than-company Q2 sales results.,2020-04-30 07:51:00-04:00,HOLX,positive
623825.0,"The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1",2020-04-30 07:19:00-04:00,HOLX,positive
623826.0,"Needham Maintains Buy on Hologic, Raises Price Target to $60",2020-04-30 06:51:00-04:00,HOLX,neutral
623827.0,"SVB Leerink Maintains Outperform on Hologic, Raises Price Target to $62",2020-04-30 06:48:00-04:00,HOLX,neutral
623828.0,"Hologic Q2 Adj. EPS $0.570, Inline, Sales $756.100M Beat $747.360M Estimate",2020-04-29 16:02:00-04:00,HOLX,neutral
623829.0,Hologic Shares Rebound From Low On Volume Spike; Traders Circulate Beta.Sam.Gov Notice From Dept. Of Health And Human Services For Co.'s 'Expanding production capacity for the Panther Fusion SARS-CoV-2 assay',2020-04-29 15:13:00-04:00,HOLX,neutral
623830.0,Hologic Has Been Awarded $13M HHS Contract To Expand Production Capacity For Panther Fusion Assay,2020-04-29 15:12:00-04:00,HOLX,positive
623831.0,"The Daily Biotech Pulse: Inovio's MERS Vaccine Data, Fast Track Designation For Erytech, FDA Approves Higher Dose Of Merck's Keytruda",2020-04-29 08:40:00-04:00,HOLX,positive
623832.0,"Earnings Scheduled For April 29, 2020",2020-04-29 04:50:00-04:00,HOLX,neutral
623833.0,"UBS Maintains Neutral on Hologic, Lowers Price Target to $52",2020-04-28 11:34:00-04:00,HOLX,negative
623834.0,"The Week Ahead In Biotech (April 26-May 2): Cancer Conference, Earnings News Flow In The Spotlight",2020-04-26 16:37:00-04:00,HOLX,negative
623835.0,Shares of several healthcare companies are trading higher. Movement appears market-related as equities gain amid a rebound in oil prices.,2020-04-23 11:27:00-04:00,HOLX,positive
623836.0,Shares of several healthcare companies are trading higher amid optimistic coronavirus outlook following positive drug data from Gilead. This has raised hopes of a sooner return to spending and economic activity.,2020-04-17 10:04:00-04:00,HOLX,positive
623837.0,Shares of several healthcare companies are trading higher amid overall market strength after the US Federal Reserve announced a further $2.3 trillion in financing programs to support the economy. Other potential positive sector catalysts include demand for therapies and medical supplies amid the coronavirus pandemic and US Senator Sanders exiting the Presidential race.,2020-04-09 09:58:00-04:00,HOLX,positive
623838.0,"SVB Leerink Maintains Market Perform on Hologic, Lowers Price Target to $41",2020-04-08 11:35:00-04:00,HOLX,negative
623839.0,"Stifel Maintains Hold on Hologic, Lowers Price Target to $45",2020-04-08 08:47:00-04:00,HOLX,negative
623840.0,"Benzinga's Top Upgrades, Downgrades For April 7, 2020",2020-04-07 09:41:00-04:00,HOLX,positive
623841.0,Shares of several healthcare companies are trading higher amid optimism that coronavirus cases in Asia are potentially easing. Global slowing cases could raise hopes of a sooner return to spending and economic activity. Several companies in the sector may also be benefiting from increased demand for therapies and medical supplies amid the coronavirus pandemic.,2020-04-07 07:48:00-04:00,HOLX,positive
623842.0,"Hologic Sees Prelim. Q2 Sales $756.1M vs $756.88M Est., Withdraws Q2 And FY20 Guidance",2020-04-07 07:31:00-04:00,HOLX,neutral
623843.0,Wells Fargo Upgrades Hologic to Overweight,2020-04-07 05:04:00-04:00,HOLX,negative
623844.0,"B of A Securities Reiterates Buy on Hologic, Lowers Price Target to $50",2020-04-02 08:42:00-04:00,HOLX,positive
623845.0,"Needham Maintains Buy on Hologic, Lowers Price Target to $52",2020-04-02 06:50:00-04:00,HOLX,negative
623846.0,"Morgan Stanley Upgrades Hologic to Equal-Weight, Lowers Price Target to $40",2020-03-27 08:30:00-04:00,HOLX,negative
623847.0,"Barclays Maintains Equal-Weight on Hologic, Lowers Price Target to $43",2020-03-26 10:51:00-04:00,HOLX,negative
623848.0,"The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection",2020-03-19 07:37:00-04:00,HOLX,neutral
623849.0,"The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates",2020-03-18 07:36:00-04:00,HOLX,positive
623850.0,Hologic Shares Up 20% After Hours; Hearing Co. CEO Recently On CNBC,2020-03-17 16:18:00-04:00,HOLX,positive
623851.0,"JP Morgan Maintains Overweight on Hologic, Lowers Price Target to $50",2020-03-17 11:15:00-04:00,HOLX,negative
623852.0,"Hologic's Molecular Test for the Novel Coronavirus, SARS-CoV-2, Receives FDA Emergency Use Authorization",2020-03-16 20:09:00-04:00,HOLX,negative
623853.0,Shares of several healthcare companies are trading lower in sympathy with the overall market on continued downward momentum caused by the coronavirus. The virus has had a negative impact on the global economy.,2020-03-16 09:40:00-04:00,HOLX,negative
623854.0,Shares of several healthcare companies are trading higher as the market rebounds following Thursday's selloff. NOTE: Since the coronavirus outbreak the healthcare sector has been extremely volatile.,2020-03-13 09:29:00-04:00,HOLX,positive
623855.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-12 12:10:00-04:00,HOLX,negative
623856.0,"Hologic VP, Investor Relations, Michael Watts, Responds To Report Co.'s Coronavirus Test Won HHS Advanced Development Support, Tells Benzinga Co. Intends To File Emergency Use Authorization From FDA, Confirms Funding Is From HHS's BARDA",2020-03-09 13:41:00-04:00,HOLX,positive
623857.0,UPDATE: BARDA Will Contribute $699K To Accelerate Development Of Hologic's Coronavirus Test,2020-03-09 12:10:00-04:00,HOLX,neutral
623858.0,Hologic Shares Tick Higher On Volume Spike As Hearing Co.'s Coronavirus Test Wins Advanced Development Support By Health & Human Services,2020-03-09 12:05:00-04:00,HOLX,positive
623859.0,"The Daily Biotech Pulse: Merck Spins Off Slow-Growth Businesses, ZioPharm Announces Offering, PhaseBio Data",2020-02-05 07:43:00-05:00,HOLX,neutral
623860.0,Stocks That Hit 52-Week Highs On Tuesday,2020-02-04 10:18:00-05:00,HOLX,neutral
623861.0,"The Daily Biotech Pulse: Sanofi Reports Positive Readout, Tonix Vaccine Candidate Aces Animal Study, Hologix's Weak Guidance",2020-01-30 09:26:00-05:00,HOLX,positive
623862.0,"Hologic Sees Q2 Adj. EPS $0.61-$0.63 vs $0.63 Estimate, Sales $770M-$780M vs $811.4M Est.",2020-01-29 16:09:00-05:00,HOLX,neutral
623863.0,"Hologic Raises FY
20 Adj. EPS Guidance From $2.60-$2.65 To $2.63-$2.67 vs $2.61 Estimate",2020-01-29 16:09:00-05:00,HOLX,neutral
623864.0,UPDATE: Hologic Cuts FY20 Sales Guidance From $3.45B-$3.5B To $3.238B-$3.268B vs $3.32B Estimate,2020-01-29 16:08:00-05:00,HOLX,negative
623865.0,Hologic Cuts FY20 Guidance,2020-01-29 16:08:00-05:00,HOLX,negative
623866.0,"Hologic Q1 Adj. EPS $0.61, Inline, Sales $850.5M Beat $839.82M Estimate",2020-01-29 16:07:00-05:00,HOLX,neutral
623867.0,Stocks That Hit 52-Week Highs On Wednesday,2020-01-29 10:16:00-05:00,HOLX,neutral
623868.0,"The Daily Biotech Pulse: Novartis Earnings, Hepion's NASH Candidate Beats Rival Drugs, Annovis Bio To Debut",2020-01-29 08:30:00-05:00,HOLX,neutral
623869.0,"Earnings Scheduled For January 29, 2020",2020-01-29 04:06:00-05:00,HOLX,neutral
623870.0,"The Week Ahead In Biotech: Amgen, Eli Lilly, Pfizer In Earnings Mix, IPO Flow Resumes",2020-01-26 10:23:00-05:00,HOLX,neutral
623871.0,Stocks That Hit 52-Week Highs On Friday,2020-01-17 13:23:00-05:00,HOLX,neutral
623872.0,"The Daily Biotech Pulse: Novo Nordisk's Ozempic Receives Label Expansion For Cardiovascular Events, Adcom Disappointment Inflicts Pain On Durect Shares",2020-01-17 08:07:00-05:00,HOLX,negative
623873.0,Stocks That Hit 52-Week Highs On Thursday,2020-01-16 10:22:00-05:00,HOLX,neutral
623874.0,"The Daily Biotech Pulse: Osmotica Soars On Insider Buys, Ultragenyx's Partnered Rare Disease Drug Moves Into Clinics",2020-01-16 07:22:00-05:00,HOLX,neutral
623875.0,"The Daily Biotech Pulse: Nektar Withdraws Opioid Pain Drug NDA, Galapagos Takes Stake In Fibrocor, Integra Lifesciences Lowers Q4 Guidance",2020-01-15 08:22:00-05:00,HOLX,negative
623876.0,"Barclays Maintains Equal-Weight on Hologic, Raises Price Target to $51",2020-01-13 08:30:00-05:00,HOLX,neutral
623877.0,"Needham Maintains Buy on Hologic, Raises Price Target to $62",2020-01-13 07:51:00-05:00,HOLX,neutral
623878.0,Hologic Preliminary Q4 Revenue of $850.5M vs 839.23M Est,2020-01-12 17:05:00-05:00,HOLX,neutral
623879.0,Hologic Board of Directors Approves New $500M Share Repurchase Plan -,2020-01-12 17:03:00-05:00,HOLX,positive
623880.0,"Benzinga's Top Upgrades, Downgrades For January 8, 2020",2020-01-08 10:56:00-05:00,HOLX,positive
623881.0,"Wells Fargo Initiates Coverage On Hologic with Equal-Weight Rating, Announces $57 Price Target",2020-01-08 09:09:00-05:00,HOLX,positive
623882.0,"Citigroup Initiates Coverage On Hologic with Buy Rating, Announces $60 Price Target",2020-01-07 07:16:00-05:00,HOLX,neutral
623883.0,"Benzinga's Top Upgrades, Downgrades For January 2, 2020",2020-01-02 10:42:00-05:00,HOLX,positive
623884.0,Evercore ISI Group Downgrades Hologic to In-Line,2020-01-02 07:23:00-05:00,HOLX,neutral
623885.0,"Morgan Stanley Maintains Underweight on Hologic, Raises Price Target to $50",2019-12-17 09:08:00-05:00,HOLX,neutral
623886.0,"Stifel Nicolaus Maintains Hold on Hologic, Raises Price Target to $52",2019-12-13 09:26:00-05:00,HOLX,neutral
623887.0,"The Daily Biotech Pulse: Second Time's The Charm For Sarepta, Pfizer's Xeljanz Snags Third Approval, NewLink Genetics Rejects Competing Offer",2019-12-13 08:10:00-05:00,HOLX,positive
623888.0,Stocks That Hit 52-Week Highs On Thursday,2019-12-12 10:21:00-05:00,HOLX,neutral
623889.0,Hologic Option Alert: Dec 20 $55 Calls Sweep (2) near the Ask: 1000 @ $0.226 vs 4146 OI; Earnings 1/29 After Close [est] Ref=$52.955,2019-12-06 13:07:00-05:00,HOLX,positive
623890.0,Stocks That Hit 52-Week Highs On Friday,2019-12-06 10:33:00-05:00,HOLX,neutral
623891.0,"Hologic Filez For Mixed Shelf Offering, Size Not Disclosed",2019-11-27 09:24:00-05:00,HOLX,neutral
623892.0,Hologic shares are trading higher after the company announced it would sell its Cynosure Aesthetics unit to Clayton for $138 million.,2019-11-20 10:04:00-05:00,HOLX,positive
623893.0,"Hologix To Sell Cynosure To Clayton, Dubilier & Rice; Terms Not Disclosed",2019-11-20 07:33:00-05:00,HOLX,neutral
623894.0,Hologic Announces FDA Approval Of 3DQuorum Imaging Technology,2019-11-12 08:15:00-05:00,HOLX,positive
623895.0,"Canaccord Genuity Maintains Hold on Hologic, Lowers Price Target to $50",2019-11-11 08:27:00-05:00,HOLX,negative
623896.0,Hologic Option Alert: Nov 15 $47 Calls Sweep (30) near the Ask: 2500 @ $0.25 vs 43 OI; Ref=$45.66,2019-11-07 11:58:00-05:00,HOLX,positive
623897.0,"Hologic Shares Rebound From Session Low; Hearing Evercore ISI Suggested Buying Weakness In Shares, Calls Name A 'Beat And Raise Story'",2019-11-07 11:57:00-05:00,HOLX,negative
623898.0,Hologic shares are trading lower after the company issued soft Q1 guidance.,2019-11-07 10:16:00-05:00,HOLX,neutral
623899.0,"Hologic Sees Q1 Adj. EPS $0.59-$0.61 vs $0.63 Est., Sales $835M-$850M vs $857.08M Est.; Sees FY20 Adj. EPS $2.60-$2.65 vs $2.64 Est., Sales $3.45B-$3.50B vs $3.48B Est.",2019-11-06 16:07:00-05:00,HOLX,neutral
623900.0,"Hologic Q4 Adj. EPS $0.65, Inline, Sales $865.8M Beat $845.73M Estimate",2019-11-06 16:02:00-05:00,HOLX,neutral
623901.0,"The Daily Biotech Pulse: Sesen Rallies On Positive FDA Meeting, Supernus Flunks Late-Stage ADHD Trial, GW Pharma Earnings",2019-11-06 08:21:00-05:00,HOLX,positive
623902.0,"Earnings Scheduled For November 6, 2019",2019-11-06 04:13:00-05:00,HOLX,neutral
623903.0,"Shares of several healthcare stocks are trading lower in sympathy with the overall market after the Institute for Supply Management said U.S. manufacturing activity shrunk to its lowest level since June 2009, adding fears of an economic slowdown.",2019-10-01 13:02:00-04:00,HOLX,negative
623904.0,"Benzinga's Top Upgrades, Downgrades For September 26, 2019",2019-09-26 09:40:00-04:00,HOLX,positive
623905.0,Bank of America Upgrades Hologic to Buy,2019-09-26 08:12:00-04:00,HOLX,neutral
623906.0,Hologic Option Alert: Sep 20 $50 Calls Sweep (31) near the Ask: 928 @ $1.6 vs 288 OI; Ref=$50.17,2019-08-12 10:34:00-04:00,HOLX,positive
623907.0,Hologic Reports Purchase Of ~46% Of Shares In SuperSonic Imagine For ~$42M,2019-08-01 16:58:00-04:00,HOLX,positive
623908.0,Hologic shares are trading higher after the company reported better-than-expected Q3 EPS and sales results. The company also raised FY19 sales guidance above analyst estimates.,2019-07-31 16:08:00-04:00,HOLX,positive
623909.0,Hologix Sees Q4 Adj. EPS $0.64-$0.66 vs $0.65 Est.,2019-07-31 16:06:00-04:00,HOLX,neutral
623910.0,"Hologic Narrows FY19 Adj. EPS Guidance From $2.41-$2.44 To $2.42-$2.44 vs $2.42 Est., Raises Sales Guidance From $3.325B-$3.345B To $3.335B-$3.350B vs $3.33B Est.",2019-07-31 16:05:00-04:00,HOLX,neutral
623911.0,"Hologic Q3 Adj. EPS $0.63 Beats $0.61 Estimate, Sales $852.4M Beat $835.74M Estimate",2019-07-31 16:03:00-04:00,HOLX,neutral
623912.0,Hologic Option Alert: Aug 16 $55 Calls Sweep (29) near the Ask: 1603 @ $0.401 vs 289 OI; Earnings 7/31 After Close Ref=$52.04,2019-07-31 13:41:00-04:00,HOLX,positive
623913.0,Stocks That Managed to Breach 52-Week Highs Wednesday Morning,2019-07-31 11:01:00-04:00,HOLX,neutral
623914.0,A Preview Of Hologic's Q3 Earnings,2019-07-31 08:09:00-04:00,HOLX,neutral
623915.0,"The Daily Biotech Pulse: Roche-Spark Deal Faces Further Delay, Bayer's Prostate Cancer Drug Passes FDA Muster",2019-07-31 07:06:00-04:00,HOLX,negative
623916.0,New Stocks that Broke Through 52-Week Highs Tuesday Morning,2019-07-30 10:34:00-04:00,HOLX,negative
623917.0,"The Daily Biotech Pulse: European Cheer For Merck, Legal Victory For Coherus, Medpace Picks Up On Earnings",2019-07-30 07:00:00-04:00,HOLX,positive
623918.0,New Equities that Broke Through 52-Week Highs Monday Morning,2019-07-29 10:13:00-04:00,HOLX,negative
623919.0,"The Daily Biotech Pulse: ContraVir's Volatile Ride Continues, Late-Stage Disappointment For Exelixis, Regeneron-Sanofi Breathe Easy",2019-06-21 07:18:00-04:00,HOLX,negative
623920.0,"Hologic Enters Into Exclusive Negotiations To Acquire SuperSonic Imagine, French Ultrasound Innovator For €1.50/Share",2019-06-20 16:01:00-04:00,HOLX,positive
623921.0,"The Daily Biotech Pulse: DiaMedica Reports Positive Data For Chronic Kidney Disease Drug, Eloxx Offering, IPO Deluge",2019-06-20 07:25:00-04:00,HOLX,positive
623922.0,Hologic Reports Partnership With DEXA+ To Distribute Body Composition Measurement System,2019-05-30 08:32:00-04:00,HOLX,neutral
623923.0,Hologic Reports FDA Clearance For Its Aptime BV And Aptima CV/TV Assays For Diagnosing Vaginitis,2019-05-29 08:11:00-04:00,HOLX,neutral
623924.0,"Shares of several healthcare companies are trading higher as the US market rebounds from recent weakness, driven by renewed cautious optimism surrounding US-China trade talks.",2019-05-14 13:32:00-04:00,HOLX,positive
623925.0,"Hologic Q2 EPS $0.58 Beats $0.57 Estimate, Sales $818.4M Beat $806.03M Estimate",2019-05-01 16:03:00-04:00,HOLX,neutral
623926.0,Hologic's Q2 Earnings Preview,2019-05-01 11:48:00-04:00,HOLX,neutral
623927.0,"The Daily Biotech Pulse: Nabriva Stumbles At FDA Hurdle, Gilead CFO To Retire, Eisai Ends Collaboration With Purdue",2019-05-01 07:39:00-04:00,HOLX,neutral
623928.0,"Hologic Launches Trident HD Specimen Radiography System In United States, Canada And Europe",2019-04-25 09:16:00-04:00,HOLX,positive
623929.0,Shares of several medical device companies are trading lower with the healthcare sector. Healthcare has seen weakness recently due to concerns over the future of the Affordable Act under Trump and healthcare policy uncertainty ahead of the 2020 election.,2019-04-17 12:45:00-04:00,HOLX,negative
623930.0,Hologic Receives CE Mark For Three-In-One Omni Hysteroscope In Europe,2019-03-04 08:01:00-05:00,HOLX,neutral
623931.0,Hologic Reports European CE Mark For LOCalizer Wireless Breast Lesion Localization System,2019-02-27 08:04:00-05:00,HOLX,neutral
623932.0,"The Daily Biotech Pulse: Hologic, Celgene Earnings, FDA To Rule On Alkermes Depression Drug",2019-01-31 09:01:00-05:00,HOLX,negative
623933.0,"UPDATE: Hologic Raises FY19 Adj. EPS Guidance From $2.38-$2.42 To $2.39-$2.43 vs $2.41 Estimate, Sales $3.29B-$3.335B To $3.305B-$3.335B vs $3.32B Est.",2019-01-30 16:04:00-05:00,HOLX,neutral
623934.0,Hologic Raises FY Outlook,2019-01-30 16:04:00-05:00,HOLX,neutral
623935.0,"Hologic Q1 EPS $0.58 Beats $0.57 Estimate, Sales $830.7M Beat $814.93M Estimate",2019-01-30 16:03:00-05:00,HOLX,neutral
623936.0,"The Daily Biotech Pulse: Roche Scraps Alzheimer's Disease Trials, Amgen Issues Weak Guidance",2019-01-30 08:12:00-05:00,HOLX,negative
623937.0,"Earnings Scheduled For January 30, 2019",2019-01-30 04:06:00-05:00,HOLX,neutral
623938.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings",2019-01-27 16:07:00-05:00,HOLX,neutral
623939.0,FDA Permits Marketing Of First Test To Aid In The Diagnosis Of A Sexually-transmitted Infection Known As Mycoplasma Genitalium,2019-01-23 15:58:00-05:00,HOLX,neutral
623940.0,Hologic shares are trading higher after the company raised Q1 sales guidance to $831 million.,2019-01-07 10:05:00-05:00,HOLX,positive
623941.0,Hologic Raises Q1 Sales Guidance from $800.0M-815.0M to $831.0M vs $811.33M Est,2019-01-07 08:18:00-05:00,HOLX,neutral
623942.0,"Benzinga's Bulls & Bears Of The Week: Amazon, CBS, Intel, Nike, Tesla And More",2019-01-06 09:27:00-05:00,HOLX,positive
623943.0,"Benzinga's Top Upgrades, Downgrades For January 4, 2019",2019-01-04 09:14:00-05:00,HOLX,positive
623944.0,Cowen & Co. Downgrades Hologic to Market Perform,2019-01-04 06:50:00-05:00,HOLX,neutral
623945.0,66 Biggest Movers From Yesterday,2019-01-03 05:00:00-05:00,HOLX,neutral
623946.0,45 Stocks Moving In Wednesday's Mid-Day Session,2019-01-02 12:21:00-05:00,HOLX,neutral
623947.0,"Morgan Stanley Downgrades Hologic On Tough Cynosure Recovery, Surgery Business Risks",2019-01-02 11:01:00-05:00,HOLX,negative
623948.0,Hologic shares are trading lower after Morgan Stanley downgraded the stock from Equal-Weight to Underweight and lowered the price target from $44 to $39.,2019-01-02 10:27:00-05:00,HOLX,negative
623949.0,"Benzinga's Top Upgrades, Downgrades For January 2, 2019",2019-01-02 09:15:00-05:00,HOLX,positive
623950.0,"Morgan Stanley Downgrades Hologic to Underweight, Lowers Price Target to $39",2019-01-02 07:25:00-05:00,HOLX,negative
623951.0,"The Daily Biotech Pulse: Axovant In-Licenses 2 Gene Therapies, Agile To Undertake Additional Study Of Contraceptive Patch",2018-12-14 07:47:00-05:00,HOLX,neutral
623952.0,Hologic Reports Massachusetts Superior Court Has Granted Co. Prelim. Injunction In Trade Secrets Suits,2018-12-12 08:13:00-05:00,HOLX,positive
623953.0,"RBC Capital Maintains Sector Perform on Hologic, Raises Price Target to $46",2018-11-30 09:48:00-05:00,HOLX,neutral
623954.0,"The Daily Biotech Pulse: Nantkwest Reports Positive Cancer Vaccine Trial Results, Sarepta Offering",2018-11-08 08:10:00-05:00,HOLX,negative
623955.0,"Hologic Sees Q1 Adj. EPS $0.55-$0.57 vs $0.58 Est., Sales $800M-$815M vs $817.5M Est., Sees FY19 Adj. EPS $2.38-$2.42 vs $2.42 Est., Sales $3.29B-$$3.34B vs $3.31B Est.",2018-11-07 16:03:00-05:00,HOLX,neutral
623956.0,"Hologic Q4 Adj. EPS $0.58, Inline, Sales $813.5M Beat $806.55M Estimate",2018-11-07 16:01:00-05:00,HOLX,neutral
623957.0,"The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Momenta Strikes Patent License Deal With AbbVie",2018-11-07 07:50:00-05:00,HOLX,negative
623958.0,"Earnings Scheduled For November 7, 2018",2018-11-07 03:51:00-05:00,HOLX,neutral
623959.0,"The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-11-04 13:35:00-05:00,HOLX,neutral
623960.0,Hologic Option Alert: Nov 16 $45 Calls Sweep (38) near the Ask: 1075 @ $0.25 vs 7 OI; Earnings 11/7 After Close Ref=$38.85,2018-10-25 11:22:00-04:00,HOLX,positive
623961.0,"Morgan Stanley Maintains Equal-Weight on Hologic, Lowers Price Target to $44",2018-10-11 09:27:00-04:00,HOLX,negative
623962.0,"The Daily Biotech Pulse: Hologic Goes Shopping, Johnson & Johnson Snaps Ties With Geron",2018-09-27 08:20:00-04:00,HOLX,neutral
623963.0,Hologic To Acquire Focal Therapeutics For $125M In Cash,2018-09-26 16:01:00-04:00,HOLX,neutral
623964.0,Hologic Option Alert: Dec 21 $45 Calls Sweep (32) near the Ask: 1523 @ $0.65 vs 43 OI; Earnings 11/7 After Close [est] Ref=$41.03,2018-09-25 10:28:00-04:00,HOLX,positive
623965.0,Hologic Downgraded By BofA As Cynosure Headwinds Persist,2018-09-13 11:01:00-04:00,HOLX,neutral
623966.0,10 Biggest Price Target Changes For Thursday,2018-09-13 09:54:00-04:00,HOLX,neutral
623967.0,"Benzinga's Top Upgrades, Downgrades For September 13, 2018",2018-09-13 09:41:00-04:00,HOLX,positive
623968.0,18 Stocks Moving In Thursday's Pre-Market Session,2018-09-13 08:19:00-04:00,HOLX,neutral
623969.0,"Canaccord Genuity Maintains Hold on Hologic, Lowers Price Target to $40",2018-09-13 07:46:00-04:00,HOLX,negative
623970.0,"Bank of America Downgrades Hologic to Neutral, Lowers Price Target to $42",2018-09-13 07:42:00-04:00,HOLX,negative
623971.0,Hologic Says 'cannot yet predict when it will resume selling TempSure Vitalia',2018-09-12 16:23:00-04:00,HOLX,neutral
623972.0,"8-K From Hologic Reaffirms Guidance For Q4 Sales of $800M-$815M vs $819.88M Est., Despite Reporting That It Expects Cynosure Sales In Q4 To Be $15M Less Than Previously Forecast",2018-09-12 16:22:00-04:00,HOLX,neutral
623973.0,"Hologic 8-K Shows Co. Sees Q4 GAAP, Adj. EPS Guidance At Low End Of Previously-Issued Range",2018-09-12 16:21:00-04:00,HOLX,negative
623974.0,"Benzinga's Top Upgrades, Downgrades For September 5, 2018",2018-09-05 09:10:00-04:00,HOLX,positive
623975.0,"Barclays Downgrades Hologic to Equal-Weight, Lowers Price Target to $43",2018-09-05 06:07:00-04:00,HOLX,negative
623976.0,"Deutsche Bank Maintains Hold on Hologic, Lowers Price Target to $43",2018-08-20 07:13:00-04:00,HOLX,negative
623977.0,Hologic's Cynosure Division Signs Agreement with Porter Instrument To Exclusively Distribute Nitrous Oxide And Oxygen System In Aesthetics Market,2018-08-15 08:13:00-04:00,HOLX,positive
623978.0,"Canaccord Genuity Maintains Hold on Hologic, Lowers Price Target to $41",2018-08-14 08:04:00-04:00,HOLX,negative
623979.0,Hologic shares are trading down 4.4% following reports that the company will suspend marketing and distribution of vitalia handpieces.,2018-08-13 12:25:00-04:00,HOLX,neutral
623980.0,Hearing Hologic To Suspend Marketing And Distribution Of Vitalia Handpieces,2018-08-13 08:06:00-04:00,HOLX,negative
623981.0,Hologic Announces FDA Clearance of the Panther Fusion GBS Assay,2018-08-02 16:03:00-04:00,HOLX,neutral
623982.0,"Benzinga's Biotech Pulse: Pfizer's Xeljanz Gets EU Nod, NewLink Losses Narrow, Neuralstem Commences Stroke Drug Trial",2018-08-01 09:01:00-04:00,HOLX,negative
623983.0,"Deutsche Bank Maintains Hold on Hologic, Raises Price Target to $45",2018-08-01 08:29:00-04:00,HOLX,neutral
623984.0,Hologic Reports CFO Bob McMahon Leaving Co. To Become CFO At Agilent; Karleen Oberton Named Replacement,2018-07-31 16:05:00-04:00,HOLX,neutral
623985.0,Hologic To Acquire Faxitron Bioptics For ~$85M,2018-07-31 16:05:00-04:00,HOLX,neutral
623986.0,"Hologic Sees Q4 Adj. EPS $0.58-$0.60 vs $0.60 Estimate, Sales $800M-$815M vs $815.7M Est.",2018-07-31 16:05:00-04:00,HOLX,neutral
623987.0,Hologic Raises FY18 Sales Guidance From $3.18B-$3.21B To $3.205B-$3.22B vs $3.2B Estimate,2018-07-31 16:04:00-04:00,HOLX,neutral
623988.0,Hologic Narrows FY18 Guidance: Adj. EPS From $2.22-$2.27 To $2.24-$2.26 vs $2.23 Estimate,2018-07-31 16:04:00-04:00,HOLX,neutral
623989.0,"Hologic Q3 EPS $0.58 Beats $0.56 Estimate, Sales $824M Beat $800.44M Estimate",2018-07-31 16:03:00-04:00,HOLX,neutral
623990.0,Q3 Earnings Outlook For Hologic,2018-07-31 08:09:00-04:00,HOLX,neutral
623991.0,"Earnings Scheduled For July 31, 2018",2018-07-31 04:37:00-04:00,HOLX,neutral
623992.0,Hologic Announces U.S. International Trade Commission Finds Fujifilm Infringes on Hologic Patents In Ongoing Complaint,2018-07-30 08:07:00-04:00,HOLX,negative
623993.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings And IPOs",2018-07-28 14:04:00-04:00,HOLX,neutral
623994.0,Hologic Reports Winning Of $4.8M Patent Infringement Suit Against Minerva Surgical,2018-07-27 16:02:00-04:00,HOLX,positive
623995.0,Hologic Option Alert: Jul 20 $40 Calls at the Ask: 1241 @ $1.101 vs 225 OI; Earnings 8/1 After Close [est] Ref=$39.7899,2018-06-14 14:25:00-04:00,HOLX,positive
623996.0,Hologic Option Alert: Jul 20 $41 Calls at the Ask: 1535 @ $0.281 vs 1098 OI; Earnings 8/1 After Close [est] Ref=$38.56,2018-06-12 11:23:00-04:00,HOLX,positive
623997.0,Hologic Option Alert: Sep 21 $42 Calls Sweep (36) near the Ask: 646 @ $0.7 vs 351 OI; Earnings 8/1 After Close [est] Ref=$38.45,2018-06-11 15:59:00-04:00,HOLX,positive
623998.0,WHO Deems The Products Of These Diagnostic Companies 'Essential',2018-05-22 15:13:00-04:00,HOLX,neutral
623999.0,55 Biggest Movers From Yesterday,2018-05-04 04:41:00-04:00,HOLX,neutral
624000.0,"Benzinga's Top Analyst Calls From May 3, 2018",2018-05-03 14:43:00-04:00,HOLX,positive
624001.0,37 Stocks Moving In Thursday's Mid-Day Session,2018-05-03 13:39:00-04:00,HOLX,neutral
624002.0,"Barclays Maintains Overweight on Hologic, Lowers Price Target to $50.00",2018-05-03 13:02:00-04:00,HOLX,negative
624003.0,Leerink Downgrades Hologic After 'Lower Quality' Q2 Revenue Beat,2018-05-03 12:07:00-04:00,HOLX,negative
624004.0,8 Biggest Price Target Changes For Thursday,2018-05-03 11:32:00-04:00,HOLX,neutral
624005.0,"Benzinga's Top Upgrades, Downgrades For May 3, 2018",2018-05-03 11:26:00-04:00,HOLX,positive
624006.0,"Deutsche Bank Maintains Hold on Hologic, Lowers Price Target to $42.00",2018-05-03 09:02:00-04:00,HOLX,negative
624007.0,"The Market In 5 Minutes: Tesla Earnings, Under Armour's Future, GM, Nvidia, Square And More",2018-05-03 09:00:00-04:00,HOLX,neutral
624008.0,"Benzinga's Daily Biotech Pulse: Achaogen Slumps On Mixed FDA Panel Vote, Pacific Biosciences Sinks On Q1 Miss",2018-05-03 08:31:00-04:00,HOLX,negative
624009.0,27 Stocks Moving In Thursday's Pre-Market Session,2018-05-03 08:04:00-04:00,HOLX,neutral
624010.0,"Leerink Swann Downgrades Hologic to Market Perform, Lowers Price Target to $41",2018-05-03 07:47:00-04:00,HOLX,negative
624011.0,Canaccord Genuity Downgrades Hologic to Hold,2018-05-03 06:18:00-04:00,HOLX,neutral
624012.0,Hologic Shares Down 6.2% After Hours As Co. Lowers FY18 Guidance,2018-05-02 18:11:00-04:00,HOLX,positive
624013.0,Hologic Sees FY2018 EPS $2.22-2.27 vs $2.26 Est; Lowers FY2018 Sales Guidance from $3.20B-3.28B to $3.18B-3.21B vs $3.25B Est,2018-05-02 16:03:00-04:00,HOLX,negative
624014.0,"Hologic Q2 EPS $0.53, Inline, Sales $789.3M Beat $781.84M Estimate",2018-05-02 16:02:00-04:00,HOLX,neutral
624015.0,"Benzinga's Daily Biotech Pulse: SIGA Rallies On FDA Panel Backing, Rigel And Gilead React To Earnings",2018-05-02 07:41:00-04:00,HOLX,neutral
624016.0,"The Week Ahead In Biotech: PDUFA Dates, Clinical Trials, Merck And Pfizer Earnings On Tap",2018-04-29 08:11:00-04:00,HOLX,neutral
624017.0,Hologic Announces FDA Approval of ThinPrep Integrated Imager,2018-04-25 08:05:00-04:00,HOLX,positive
624018.0,"Enzo Biochem Reports Enzo Life Sciences Unit Denied Petition Filed BY Hologic For PTAB Against US Patent 6,221,581",2018-04-24 10:01:00-04:00,HOLX,negative
624019.0,Hologic's SculpSure Body Contouring Treatment Scores Distribution Win,2018-04-17 15:26:00-04:00,HOLX,positive
624020.0,"UPDATE: Evercore ISI On Hologic: 'With sentiment on HOLX at an all-time low, today's announcement provides one of the first proof points that the CYNO deal
was the right move for HOLX...'",2018-04-17 10:09:00-04:00,HOLX,negative
624021.0,UPDATE: Evercore ISI Says CYNO Sculpsure With LightRx Deal Is 'Huge Win' For Hologic,2018-04-17 10:08:00-04:00,HOLX,positive
624022.0,"Evercore ISI On Hologic Discusses CYNO Sculpsure With LightRx Deal, Says 'Assuming 1 system per center and $175k per system, this could be ~$14 MM revenue opportunity'",2018-04-17 10:07:00-04:00,HOLX,positive
624023.0,Innovations for Hologic's Clarity HD are Approved by the FDA,2018-03-27 08:16:00-04:00,HOLX,positive
624024.0,"Philips, Hologic Announce Global Partnership Agreement to Provide Integrated Imaging Solutions for Women's Health",2018-03-02 03:54:00-05:00,HOLX,positive
624025.0,Hologic Reports Signing Of Exclusive Deal With DEXALYTICS To Offer Body Composition Analysis Software For Athletes,2018-02-22 08:14:00-05:00,HOLX,positive
624026.0,"Benzinga's Top Upgrades, Downgrades For February 9, 2018",2018-02-09 10:17:00-05:00,HOLX,positive
624027.0,Stifel Nicolaus Downgrades Hologic to Hold,2018-02-09 07:15:00-05:00,HOLX,neutral
624028.0,"Hologic Raises FY18 EPS Guidance From $2.10-$2.15 To $2.22-$2.27, Reiterates Sales Guidance",2018-02-08 16:04:00-05:00,HOLX,neutral
624029.0,"Hologic Raises FY18 EPS Outlook, Reaffirms Sales Guidance",2018-02-08 16:04:00-05:00,HOLX,neutral
624030.0,"Hologic Reports Q1 Adj. EPS $0.55 vs $0.50 Est., Sales $791.1M vs $785M Est.",2018-02-08 16:04:00-05:00,HOLX,neutral
624031.0,Aptima HBV Quant Assay for Quantitation of Hepatitis B Viral Load Receives PMA Approval From the FDA,2018-01-25 08:19:00-05:00,HOLX,positive
624032.0,The Top 10 Value Stocks In The S&P 500,2018-01-19 13:12:00-05:00,HOLX,positive
624033.0,"Deutsche Bank Downgrades Hologic, Says Core Businesses Face Structural Challenges",2018-01-19 10:05:00-05:00,HOLX,positive
624034.0,"Benzinga's Top Upgrades, Downgrades For January 19, 2018",2018-01-19 10:03:00-05:00,HOLX,positive
624035.0,Deutsche Bank Downgrades Hologic to Hold,2018-01-19 07:54:00-05:00,HOLX,neutral
624036.0,"Hologic To Report Q1 Earnings On Thurs., Feb 8 After Market Close",2018-01-08 11:56:00-05:00,HOLX,neutral
624037.0,Hologic Earlier Reported Prelim. Q1 Sales $791M vs $784.76M Est.,2018-01-08 11:16:00-05:00,HOLX,neutral
624038.0,"Evercore ISI Group Initiates Coverage On Hologic with Outperform Rating, Announces $50.00 Price Target",2018-01-03 08:18:00-05:00,HOLX,neutral
624039.0,"UPDATE: Goldman Added Alnylam and Biomarin To 2018 Conviction Buy List Earlier This Morning, Hologic Was Added To Conviction Buy List On 12/7 For 2018",2017-12-15 08:56:00-05:00,HOLX,neutral
624040.0,"Goldman Adds Biomarin, Alnylam To Conviction Buy List For 2018; Earlier Post Said That Hologic Was Added To Conviction Buy List For 2018, That Note Was Updated Today, But Was Originally Published 12/7",2017-12-15 08:25:00-05:00,HOLX,neutral
624041.0,Cowen: Hologic Is A Relatively Cheap Stock Overdue For Upside,2017-12-11 11:09:00-05:00,HOLX,neutral
624042.0,5 Biggest Price Target Changes For Monday,2017-12-11 09:48:00-05:00,HOLX,neutral
624043.0,"Benzinga's Top Upgrades, Downgrades For December 11, 2017",2017-12-11 09:31:00-05:00,HOLX,positive
624044.0,Cowen & Co. Upgrades Hologic to Outperform,2017-12-11 07:22:00-05:00,HOLX,neutral
624045.0,Hologic: Meet Goldman Sach's New 'Conviction Buy',2017-12-08 11:56:00-05:00,HOLX,neutral
624046.0,Goldman Adds Hologix To Conviction Buy List,2017-12-08 08:23:00-05:00,HOLX,neutral
624047.0,Third Respiratory Assay Now FDA Cleared on Hologic's New Panther Fusion System,2017-12-06 08:08:00-05:00,HOLX,positive
624048.0,Hologic Option Alert: Jan 19 $42 Calls Sweep (20) at the Bid: 824 @ $1.413 vs 935 OI; Ref=$42.19,2017-12-04 10:03:00-05:00,HOLX,positive
624049.0,Hologic Earlier Announced a Development and Distribution Agreement with Clarius Mobile Health,2017-11-27 06:49:00-05:00,HOLX,positive
624050.0,Hologic Receives FDA 510(k) Clearance of Quantra 2.2 Breast Density Assessment Software,2017-11-24 08:07:00-05:00,HOLX,neutral
624051.0,10 Stocks Moving In Wednesday's After-Hours Session,2017-11-08 17:10:00-05:00,HOLX,neutral
624052.0,"Hologic Sees FY18 Adj. EPS $2.10-$2.15 vs $2.15 Est., Sales $3.2B-$3.28B vs $3.3B Est.",2017-11-08 16:03:00-05:00,HOLX,neutral
624053.0,"Hologic Reports Q4 Adj. EPS $0.50 vs $0.49 Est., Sales $802.9M vs $792.5M Est.",2017-11-08 16:02:00-05:00,HOLX,neutral
624054.0,"Earnings Scheduled For November 8, 2017",2017-11-08 04:11:00-05:00,HOLX,neutral
624055.0,Hologic Option Alert: Dec 15 $38 Puts Sweep (14) at the Bid: 743 @ $1.404 vs 831 OI; Ref=$38.4899 Signals,2017-11-01 10:53:00-04:00,HOLX,positive
624056.0,Hologic Launches the MyoSure MANUAL Device to Help Doctors Remove Intrauterine Tissue In-Office,2017-11-01 08:09:00-04:00,HOLX,positive
624057.0,Hologic Reports It's Received 510(k) Clearance From FDA For Its Panther Fusion Paraflu Assay,2017-10-26 08:12:00-04:00,HOLX,neutral
624058.0,Hologic Reports Paraflu Assay Now FDA Cleared On Co.'s New Panther Fusion System,2017-10-26 08:10:00-04:00,HOLX,positive
624059.0,Hologic Reports Amended 5-Year $1.5B Senior Term Loan And $1.5B Revolving Credit Facility,2017-10-04 07:03:00-04:00,HOLX,positive
624060.0,Hologic Receives FDA 510(k) Clearance to Market SculpSure,2017-09-27 08:03:00-04:00,HOLX,neutral
624061.0,"Hologic Shares Tick To Session Lows, Quickly Rebound As Traders Circulate USPSTF Recommendation Draft Showing An Update: Cotesting Is No Longer Recommended",2017-09-12 14:03:00-04:00,HOLX,neutral
624062.0,"Amended 8-K From Hologic Shows Raised FY17 Outlook: Adj. EPS From $1.98-$2.02 To $2-$2.02 vs $2.01 Est., Sales Lowered From $3.05B-$3.08B To $3.04-$3.055B vs $3.07B Est.",2017-08-03 10:31:00-04:00,HOLX,negative
624063.0,"Goldman Sachs Maintains Buy on Hologicto Buy, Removes Co. From Conviction Buy List",2017-08-03 09:41:00-04:00,HOLX,neutral
624064.0,"Hologic Reports Q3 EPS $0.50 vs. $0.49 Est., Sales 806.1M vs. $799.7M Est.",2017-08-02 16:06:00-04:00,HOLX,neutral
624065.0,"Earnings Scheduled For August 2, 2017",2017-08-02 04:35:00-04:00,HOLX,neutral
624066.0,Watch These 7 Huge Call Purchases In Thursday Trade,2017-07-13 04:21:00-04:00,HOLX,positive
624067.0,Benzinga's Option Alert Recap From July 12,2017-07-12 16:18:00-04:00,HOLX,positive
624068.0,Holgic Option Alert: Aug 18 $50 Calls at the Ask: 4625 @ $0.25 vs 194 OI; Ref=$44.97,2017-07-12 11:46:00-04:00,HOLX,positive
624069.0,"Hologic Reports Panther Fusion System, Assays Win CE Mark In Europe",2017-06-29 08:08:00-04:00,HOLX,positive
624071.0,Hologic Reports FDA Clearance Of Aptima Assay To Detect Herpes Simplex Virus 1 & 2,2017-06-20 08:02:00-04:00,HOLX,neutral
624073.0,Hologic Receives Expanded FDA 510(k) Clearance to Market Cynosure's SculpSure,2017-06-15 08:03:00-04:00,HOLX,neutral
624075.0,Hologic's Genius 3D Mammography Exam Receives FDA Approval,2017-06-07 08:01:00-04:00,HOLX,positive
624076.0,25 Stocks Moving In Tuesday's Pre-Market Session,2017-05-16 08:05:00-04:00,HOLX,neutral
624077.0,Watch These 3 Huge Put Purchases In Thursday Trade,2017-05-11 04:19:00-04:00,HOLX,positive
624078.0,Benzinga's Option Alert Recap From May 10,2017-05-10 16:59:00-04:00,HOLX,positive
624079.0,"Hologic Sees Q3 EPS $0.48-$0.50 vs $0.50 Est., Sales $790-$805M vs $815M Est.",2017-05-10 16:07:00-04:00,HOLX,neutral
624080.0,"UPDATE: Hologic Raises FY17 Guidance EPS From $2.78-$2.82B To $3.05-$3.08B, EPS From 1.90-$1.94 To $1.98-$2.02",2017-05-10 16:06:00-04:00,HOLX,neutral
624081.0,"Hologic Sees FY17 Sales $3.05-$3.08B vs $3.06B Est., EPS $1.98-$2.02 vs $1.98 Est.",2017-05-10 16:05:00-04:00,HOLX,neutral
624082.0,"Hologic Reports Q2 Adj. EPS $0.50 vs $0.46 Est., Sales $715M vs $685M Est.",2017-05-10 16:04:00-04:00,HOLX,neutral
624083.0,Option Alert: Hologic Jun 45.0 Puts Sweep: 1653 @  ASK  $1.241: 1653 traded vs 55 OI:  Earnings today After Close  $45.67 Ref,2017-05-10 12:56:00-04:00,HOLX,positive
624084.0,"Earnings Scheduled For May 10, 2017",2017-05-10 04:56:00-04:00,HOLX,neutral
624085.0,Adoption Of 3D Mammography Appears To Be On The Cusp Of An Inflection,2017-03-13 09:59:00-04:00,HOLX,neutral
624086.0,FDA Grants PMA Approval for Hologic's Aptima Hepatitis C Quant Dx Assay,2017-02-15 16:35:00-05:00,HOLX,neutral
624087.0,"Benzinga's Top Upgrades, Downgrades For February 15, 2017",2017-02-15 09:39:00-05:00,HOLX,positive
624088.0,Needham Upgrades Hologic To Buy,2017-02-15 09:26:00-05:00,HOLX,neutral
624089.0,Wall Street's M&A Chatter From February 14,2017-02-15 06:48:00-05:00,HOLX,neutral
624090.0,Bank of America Downgrades Hologic To Neutral,2017-02-15 06:36:00-05:00,HOLX,neutral
624091.0,Mid-Afternoon Market Update: Dow Rises Over 50 Points; Hibbett Shares Slide On Weak Outlook,2017-02-14 14:52:00-05:00,HOLX,negative
624092.0,18 Biggest Mid-Day Gainers For Tuesday,2017-02-14 12:28:00-05:00,HOLX,neutral
624093.0,Mid-Day Market Update: RetailMeNot Gains After Strong Q4 Results; Aviragen Therapeutics Shares Plunge,2017-02-14 12:01:00-05:00,HOLX,positive
624094.0,Mid-Morning Market Update: Markets Edge Lower; T-Mobile Beats Q4 Views,2017-02-14 09:56:00-05:00,HOLX,negative
624095.0,Benzinga's Option Alert Recap From February 3,2017-02-03 16:46:00-05:00,HOLX,positive
624096.0,Option Alert: Hologics  Feb 40.0 Calls Sweep: 2698 @  ASK  $0.448: 2699 traded vs 643 OI:  Earnings 4/26 After Close (est)  $39.25 Ref,2017-02-03 11:37:00-05:00,HOLX,positive
624097.0,"Hologic Sees Q2 REv. $675-$685M vs. Est. $720M, EPS $0.45-$0.46 vs. Est. $0.51",2017-02-01 16:03:00-05:00,HOLX,neutral
624098.0,"Hologic Sees FY17 Rev. $2.785-$2.82B vs. Est. $2.96B, Lowers FY17 EPS From $2.12-$2.16 To $1.90-$1.94",2017-02-01 16:02:00-05:00,HOLX,negative
624099.0,"Hologic Reports Q1 EPS $0.52 vs. Est. $0.51, Rev. $734M vs. Est. $724M",2017-02-01 16:01:00-05:00,HOLX,neutral
624100.0,"Earnings Scheduled For February 1, 2017",2017-02-01 04:09:00-05:00,HOLX,neutral
624101.0,Deutsche Bank Optimistic On Fundamentals In Life Science Tools/Diagnostics Sector,2017-01-18 12:29:00-05:00,HOLX,positive
624102.0,"Deutsche Bank Initiates Coverage On Hologic At Buy, Announces $48 Price Target",2017-01-18 08:35:00-05:00,HOLX,neutral
624103.0,Deutsche Bank Initiates Coverage on Medical Equipment Names,2017-01-17 17:59:00-05:00,HOLX,neutral
624104.0,7 Biggest Price Target Changes For Wednesday,2017-01-04 09:55:00-05:00,HOLX,neutral
624105.0,"Benzinga's Top Upgrades, Downgrades For January 4, 2017",2017-01-04 09:41:00-05:00,HOLX,positive
624106.0,"PiperJaffray Upgrades Hologic to Overweight, Raises Target to $48.00",2017-01-04 07:52:00-05:00,HOLX,negative
624107.0,Evercore ISI Group Downgrades Hologic to Hold,2017-01-04 07:51:00-05:00,HOLX,neutral
624108.0,Hologic Grands PMA Approval for HIV-1 Quant Assay,2017-01-03 08:01:00-05:00,HOLX,positive
624109.0,"Hologic Shares Open for Trade, Indicated Higher But Not Yet Seeing Last Price",2016-12-14 16:31:00-05:00,HOLX,positive
624110.0,Hologic Shares to Resume Trade at 4:30 p.m. EST,2016-12-14 16:11:00-05:00,HOLX,positive
624111.0,"UPDATE: Hologic Had Expected Blood Screening Unit to Contribute ~$240M in FY17 Sales, $0.34 to Adj. EPS Figure",2016-12-14 16:02:00-05:00,HOLX,neutral
624112.0,Hologic Will Divest Blood Screening Unit to Partner Grifols $1.85B,2016-12-14 16:01:00-05:00,HOLX,neutral
624113.0,Hologic Shares Halted News Pending,2016-12-14 16:01:00-05:00,HOLX,positive
624114.0,10 Stocks That Closed Highest In A Week,2016-12-13 05:37:00-05:00,HOLX,neutral
624115.0,Canaccord Genuity Medical Technology And Diagnostics Forum Today,2016-11-17 09:56:00-05:00,HOLX,neutral
624116.0,Stifel Healthcare Conference Continues Today,2016-11-16 10:26:00-05:00,HOLX,neutral
624117.0,"Hologic Sees FY17 Rev. $2.94-$2.98B vs. Est. $2.93B, EPS $2.12-$2.16 vs. Est. $2.13; Q1 Rev. $720-$730M vs. Est. $718M, EPS $0.50-$0.51 vs. Est. $0.51",2016-11-02 16:50:00-04:00,HOLX,neutral
624118.0,"Hologic Reports Q4 EPS $0.52 vs. Est. $0.50, Rev. $726.8M vs. Est. $721M",2016-11-02 16:49:00-04:00,HOLX,neutral
624119.0,17 Stocks Which Rallied Three Days On Increasing Volume,2016-10-05 08:44:00-04:00,HOLX,neutral
624120.0,Hologic Investors Cheer As Barclays Upgrades To Overweight: 'Stronger For Longer' On Breast Health,2016-09-23 10:12:00-04:00,HOLX,positive
624121.0,Benzinga's Top Upgrades,2016-09-23 09:20:00-04:00,HOLX,positive
624122.0,"Barclays Upgrades Hologic to Overweight, Raises PT to $44.00",2016-09-23 06:06:00-04:00,HOLX,negative
624123.0,"Dir Linehan Buys 10,000 Shares of Condor Hospitality Trust @$1.85/Share -Form 4",2016-09-09 14:47:00-04:00,HOLX,positive
624124.0,Option Alert: HOLX Sep $30 Call; 3500 @Bid @$2.35; Ref=$37.40,2016-09-09 14:46:00-04:00,HOLX,positive
624125.0,FDA Expands Emergency Use Authorization for Hologic's Aptima Zika Virus Assay to Include Use with Urine Samples,2016-09-08 16:01:00-04:00,HOLX,negative
624126.0,Shares of Hologic Volatile Following Cigna News of Revised Policy for 3D Mammography Breast Cancer Screening,2016-08-23 11:02:00-04:00,HOLX,negative
624127.0,"UPDATE: Hologic Deal with Dept. of HHS Could Be Extended Up to 18 Months, $6.2M Will Support Study",2016-08-09 13:26:00-04:00,HOLX,positive
624128.0,Hearing Dept. of Health and Human Services Has Announced One-Year Deal with Hologic for Advancement of Development for Procleix Zika Virus Assay,2016-08-09 13:24:00-04:00,HOLX,neutral
624129.0,Goldman Sachs Positive On Hologic And Thermo Fisher,2016-08-03 08:56:00-04:00,HOLX,positive
624130.0,Strength Of Surgical Segment Helps Hologic To A Strong Q3,2016-07-28 14:10:00-04:00,HOLX,positive
624131.0,Benzinga's Top Upgrades,2016-07-28 08:56:00-04:00,HOLX,positive
624132.0,Evercore ISI Group Upgrades Hologic to Buy,2016-07-28 06:39:00-04:00,HOLX,neutral
624133.0,"Hologic Increases Guidance FY16 To EPS $1.93-$1.94 vs $1.91 Est, Sales $2.82B to $2.83B vs $2.82B Est",2016-07-27 16:04:00-04:00,HOLX,neutral
624134.0,"Hologic Reports Q3 EPS $0.51 vs $0.48 Est, Sales $717.4M vs $704.27M Est",2016-07-27 16:02:00-04:00,HOLX,neutral
624135.0,Option Alert: HOLX Aug16 35.0 Puts Sweep: 610 @  ASK  $0.55: 1529 traded vs 161 OI:  Earnings today After Close  $37.15 Ref,2016-07-27 15:58:00-04:00,HOLX,positive
624136.0,Option Alert: HOLX Jul16 36.0 Calls Sweep: 585 @  ASK  $0.35: 585 traded vs 3655 OI:  Earnings 7/27 After Close  $36.20 Ref,2016-07-14 09:37:00-04:00,HOLX,positive
624137.0,Option Alert: HOLX Jul16 36.0 Calls Sweep: 552 @  ASK  $0.50: 850 traded vs 3776 OI:  Earnings 7/27 After Close  $35.90 Ref,2016-07-08 15:41:00-04:00,HOLX,positive
624138.0,Watch These 8 Huge Call Purchases In Friday Trade,2016-07-08 02:44:00-04:00,HOLX,positive
624139.0,Option Alert: HOLX Sep16 35.0 Calls: 2000 @  ASK  $1.95: 2000 traded vs 105 OI:  Earnings 7/27 After Close  $35.38 Ref,2016-07-07 10:04:00-04:00,HOLX,positive
624140.0,Watch These 8 Huge Call Purchases In Friday Trade,2016-06-24 04:28:00-04:00,HOLX,positive
624141.0,Option Alert: HOLX Jul16 36.0 Calls Sweep: 632 @  ASK  $0.39: 2199 traded vs 146 OI:  Earnings 8/3  $34.89 Ref,2016-06-23 10:18:00-04:00,HOLX,positive
624142.0,Option Alert: HOLX Jul16 36.0 Calls Sweep: 555 @  ASK  $0.30: 561 traded vs 146 OI:  Earnings 8/3  $34.75 Ref,2016-06-23 10:02:00-04:00,HOLX,positive
624143.0,"Hologic Deserves To Trade At A Premium, Says Bank Of America",2016-06-21 17:52:00-04:00,HOLX,neutral
624144.0,"Jefferies Likes Hologic For Zika, But Sees Blood Screening As Larger Opportunity",2016-06-20 18:27:00-04:00,HOLX,positive
624145.0,FDA Approves Use Of Zika Virus Blood Screener From Hologic And Grifols,2016-06-20 16:55:00-04:00,HOLX,positive
624146.0,Hologic And Grifols Get FDA Approval For Procleix Zika Virus Assay,2016-06-20 10:59:00-04:00,HOLX,positive
624147.0,Hologic Reports FDA Approved Use of Procleix Zika Virus Assay and Grifols to SCreen,2016-06-20 08:00:00-04:00,HOLX,positive
624148.0,"Hologic William Blair Growth Conf. Slides Reaffirms FY16 Rev. $2.81-$2.83B vs. Est. $2.82B, EPS $1.89-$1.91 vs. Est. $1.91",2016-06-15 11:27:00-04:00,HOLX,positive
624149.0,It's 13F Season: All Of Carl Icahn's Positions,2016-05-16 18:20:00-04:00,HOLX,neutral
624150.0,13F from Carl Icahn Shows Liquidated Position in Hologic,2016-05-16 16:22:00-04:00,HOLX,neutral
624151.0,"Goldman Removes Hologic From Conviction Buy List, Maintains Buy",2016-04-29 10:10:00-04:00,HOLX,neutral
624152.0,"Hologic Removed From Goldman Sachs Americas Conviction List, Maintains Buy And $45 PT",2016-04-29 04:23:00-04:00,HOLX,neutral
624153.0,The Market In 5 Minutes: Thumbs Up,2016-04-28 10:36:00-04:00,HOLX,neutral
624154.0,Benzinga's Top Downgrades,2016-04-28 09:44:00-04:00,HOLX,positive
624155.0,Needham Downgrades Hologic to Hold,2016-04-28 07:54:00-04:00,HOLX,neutral
624156.0,"Hologic Reports Q2 EPS $0.47 vs. Est. $0.46, Rev. $693.3M vs. Est. $687M",2016-04-27 16:02:00-04:00,HOLX,neutral
624157.0,Hologic Study Results Published in JAMA Conclude that 3D MAMMOGRAPHY Exams Outperform Conventional Mammography for Women with Both Dense and Nondense Breasts,2016-04-26 16:25:00-04:00,HOLX,neutral
624158.0,"Hologic Reports FDA Clearance, Commercial Availability of Affirm Prone Biopsy System",2016-04-21 08:05:00-04:00,HOLX,neutral
624159.0,Hologic Holder Carl Icahn Reports 3.61 Stake As Of April 13,2016-04-13 17:01:00-04:00,HOLX,neutral
624160.0,Amended 13D Filing from Carl Icahn on Hologic Shows Reduced Stake from 7.83% as of Mar. 14 to 5.58%,2016-04-04 17:06:00-04:00,HOLX,neutral
624161.0,"Hologic, Centene Shares Higher After Hours as Will Be Joining S&P 500; Abiomed to Be Added to MidCap 400, Banc of California Added to SmallCap 600",2016-03-24 18:01:00-04:00,HOLX,positive
624162.0,Hologic Shares Tick Lower as Amended 13D Filing from Carl Icahn Shows Reduced Stake to 7.83%,2016-03-14 16:59:00-04:00,HOLX,neutral
624163.0,UPDATE: Amended 13D Filing from Icahn on Hologic Shows Standstill Agreement Has Been Terminated,2016-03-04 08:41:00-05:00,HOLX,positive
624164.0,"Carl Icahn, In Tandem with Tweets on Hologic, Files Amended 13D Showing 8.92% Stake",2016-03-04 08:40:00-05:00,HOLX,neutral
624165.0,Carl Icahn @Carl_C_Icahn Tweet:  Yesterday our designees resigned from the $HOLX board because the situation no longer calls for activism.,2016-03-04 08:37:00-05:00,HOLX,negative
624166.0,Needham Upgrades Hologic to Buy,2016-01-28 08:40:00-05:00,HOLX,neutral
624167.0,12 Stocks Moving In Thursday's Pre-Market Session,2016-01-28 08:24:00-05:00,HOLX,neutral
624168.0,"Hologics Sees Q1 2016 EPS $0.45-$0.46 Vs Est $0.45, Sales $680M-$690M Vs Est $695.49M",2016-01-27 16:04:00-05:00,HOLX,neutral
624169.0,"Hologics Sees FY 2016 EPS $1.86-$1.90 Vs Est $1.82, Sales $2.80B-$2.83B Vs Est $2.84B",2016-01-27 16:04:00-05:00,HOLX,neutral
624170.0,"Hologic Reports Q1 EPS $0.46 Vs Est $0.42, Sales $695.2M Vs Est $688.04M",2016-01-27 16:03:00-05:00,HOLX,neutral
624171.0,"Earnings Scheduled For January 27, 2016",2016-01-27 04:05:00-05:00,HOLX,neutral
624172.0,"Stifel Upgrades Hologix To Buy, Forecasts Co Will Obtain US Approval For Load Tests on Panther System, Expects Approval To Boost Rev Growth In 2017/2018",2015-12-11 09:10:00-05:00,HOLX,positive
624173.0,Benzinga's Top Upgrades,2015-12-11 08:50:00-05:00,HOLX,positive
624174.0,Stifel Nicolaus Upgrades Hologic to Buy,2015-12-11 06:39:00-05:00,HOLX,neutral
624175.0,Barron's Recap: Impact Investing Done Right,2015-11-30 16:25:00-05:00,HOLX,neutral
624176.0,"Hologic Reports Q4 Adj EPS $0.43 Vs Est $0.42; Sees EPS Growth At 2X Current Rate, FY 2016 Rev Growth In Mid-Single-Digits",2015-11-04 16:32:00-05:00,HOLX,positive
624177.0,Hologic Shares Up ~2.5% Post Market Following Co. Press Release Disclosing Receiving of European Regulatory Approval for New Molecular Test to Confirm Hep C Infection,2015-10-20 16:40:00-04:00,HOLX,positive
624178.0,25 Tactical Trades Goldman Sachs Is Watching Amid Earnings Season,2015-10-08 13:47:00-04:00,HOLX,neutral
624179.0,Icahn: I Believe It'll All Work Out With Freeport-McMoRan,2015-10-08 06:53:00-04:00,HOLX,neutral
624180.0,Option Alert: $HOLX Oct $39 Call Sweep; 3573 Contracts @Ask @$0.85; Now $38.97,2015-10-05 12:29:00-04:00,HOLX,positive
624181.0,Option Alert: $HOLX Nov $39 Call Sweep; 2610 Contracts @Ask @$1.95; Now $39.05,2015-10-05 10:55:00-04:00,HOLX,positive
624182.0,3D Mammograms Mean Good Things For This Stock,2015-09-18 11:28:00-04:00,HOLX,positive
624183.0,UPDATE: Icahn Shows Reduced Stake in Hologic from ~34.15M Shares Previously to ~28M Shares (9.99% Stake),2015-08-04 16:09:00-04:00,HOLX,positive
624184.0,Amended 13D Filing from Carl Icahn on Hologic Just Out,2015-08-04 16:07:00-04:00,HOLX,neutral
624185.0,Carl Icahn @Carl_C_Icahn 1/ 2  Trimmed our position but remain a huge supporter of Steve MacMillan and the @Hologic ($HOLX) team.,2015-08-04 16:07:00-04:00,HOLX,positive
624186.0,"Hologic Sees Q4 EPS $0.41-$0.42, Est $0.40 & Revs $685M-$695, Est $657.73M; Sees FY 2015 EPS $1.65-$1.66, Est $1.60 & Revs $2.687B-$2.697B, Est $2.62B",2015-07-29 16:05:00-04:00,HOLX,neutral
624187.0,"Hologic Reports Q2 EPS $0.43 Vs Est $0.39, Sales $693.9MVs Est $653.85M",2015-07-29 16:04:00-04:00,HOLX,neutral
624188.0,Benzinga's Top Initiations,2015-07-24 09:40:00-04:00,HOLX,positive
624189.0,"Bank of America Initiates Coverage on Hologic at Buy, Announces $43.00 PT",2015-07-24 07:47:00-04:00,HOLX,neutral
624190.0,Benzinga's Top Downgrades,2015-07-16 09:17:00-04:00,HOLX,positive
624191.0,BTIG Research Downgrades Hologic to Neutral,2015-07-16 07:39:00-04:00,HOLX,neutral
624192.0,Benzinga's Top Downgrades,2015-07-14 09:18:00-04:00,HOLX,positive
624193.0,"Piper Jaffray Downgrades Hologic to Neutral, Maintains $83.00 PT",2015-07-14 06:38:00-04:00,HOLX,neutral
624194.0,Benzinga's Top Downgrades,2015-07-13 09:27:00-04:00,HOLX,positive
624195.0,Evercore Partners Downgrades Hologic to Hold,2015-07-13 07:17:00-04:00,HOLX,neutral
624196.0,Hologic Announces Offering of $1.0 Billion of Senior Notes Due 2022,2015-06-18 08:20:00-04:00,HOLX,neutral
624197.0,Hologic Enters into Five-Year Secured Credit Agreement,2015-05-29 16:01:00-04:00,HOLX,positive
624198.0,"Hologic Posts Upbeat Q1 Results, Lifts Full-Year Forecast",2015-04-29 17:23:00-04:00,HOLX,neutral
624199.0,"Hologic Reports Q2 GAAP EPS $0.17, Adj. EPS $0.41 vs $0.39 Est., Sales $655.5M vs $645.5M Est.; Raises Outlook",2015-04-29 16:02:00-04:00,HOLX,neutral
624200.0,"Hologic Weighs In on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology",2015-04-16 16:11:00-04:00,HOLX,negative
624201.0,Goldman's Top 25 Tactical Trades For Earnings Season,2015-04-13 12:42:00-04:00,HOLX,positive
624202.0,"Goldman Sachs Cuts Myriad Genetics To Sell, Ups Alere",2015-03-26 15:33:00-04:00,HOLX,negative
624203.0,UBS Initiates Coverage on Hologic at Buy,2015-03-10 04:44:00-04:00,HOLX,neutral
624204.0,Needham Downgrades Hologic To  Hold,2015-03-05 08:51:00-05:00,HOLX,neutral
624205.0,Benzinga's Top Downgrades,2015-03-05 08:30:00-05:00,HOLX,positive
624206.0,Needham Downgrades Hologic to Hold,2015-03-05 05:57:00-05:00,HOLX,neutral
624207.0,Benzinga's Top Upgrades,2015-02-19 09:06:00-05:00,HOLX,positive
624208.0,Canaccord Genuity Upgrades Hologic To  Buy,2015-02-19 08:08:00-05:00,HOLX,neutral
624209.0,"Canaccord Genuity Upgrades Hologic to Buy, Raises PT to $37.00",2015-02-19 06:49:00-05:00,HOLX,neutral
624210.0,Canaccord Genuity Upgrades Hologic to Buy,2015-02-19 05:41:00-05:00,HOLX,neutral
624211.0,"Hologic Sees Q2 Adj. EPS $0.38-$0.39, FY15 Adj. EPS $1.57-$1.57",2015-01-28 16:04:00-05:00,HOLX,neutral
624212.0,"Hologic Reports Q1 Adj. EPS $0.39 vs $0.36 Est., Sales $652.8M",2015-01-28 16:02:00-05:00,HOLX,neutral
624213.0,Hologic Announces Additions to Executive Leadership Team,2015-01-20 16:03:00-05:00,HOLX,neutral
624214.0,William Blair Upgrades Hologic to Outperform,2015-01-20 08:15:00-05:00,HOLX,neutral
624215.0,Morning Market Gainers,2015-01-12 09:42:00-05:00,HOLX,neutral
624216.0,Hologic Raises Q1 Sales Guidance from $625.0M-635.0M to $653.0M,2015-01-12 08:03:00-05:00,HOLX,neutral
624217.0,"Barclays Initiates Coverage On Life Science Tools & Diagnostics, Names Thermo Fisher As 'Top Pick'",2015-01-07 16:41:00-05:00,HOLX,positive
624218.0,Hologic Jumps On Goldman Sachs News; Icahn And Other Fund Managers Are Also Bullish,2014-12-18 16:43:00-05:00,HOLX,neutral
624219.0,"Goldman Sachs Maintains Buy on Hologic, Raises PT to $33.00, Added To ""Americas Conviction Buy"" List",2014-12-18 06:57:00-05:00,HOLX,neutral
624220.0,"Hologic, Inc. Sees Q1 Adjusted EPS $0.35-0.36",2014-11-05 16:09:00-05:00,HOLX,neutral
624221.0,"Hologic, Inc. Reports Q3 EPS of $0.38 vs $0.37 Est; Revenue of $660.60 vs $636.19M Est",2014-11-05 16:03:00-05:00,HOLX,neutral
624222.0,BTIG: Hologic To Gain From Higher 3D Mammogram Reimbursements,2014-11-03 13:31:00-05:00,HOLX,positive
624223.0,Amended 13D Filing from Relational Investors on Hologic Shows Reduced Stake from 6.75% as of Jun. 30th to 4.9%,2014-10-03 17:28:00-04:00,HOLX,neutral
624224.0,Relational Investors To Wind Down Operations,2014-10-01 16:23:00-04:00,HOLX,neutral
624225.0,UPDATE: Some of Relational's Other Top Holdings: ,2014-10-01 13:54:00-04:00,HOLX,positive
624226.0,"13F from Relational Investors Shows New Stake in Whole Foods, Reduced Stake in Hologic, Raised Stakes in Yum!, Esterline, Manitowoc",2014-08-14 17:23:00-04:00,HOLX,neutral
624227.0,Hologic Reports 5.1% Passive Stake In Roka Bioscience as of July 29,2014-08-08 07:06:00-04:00,HOLX,positive
624228.0,Barrington Cuts Hologic to Market Perform from Outperform -Reuters,2014-08-05 10:22:00-04:00,HOLX,negative
624229.0,Stocks Hitting 52-Week Highs,2014-07-31 10:27:00-04:00,HOLX,neutral
624230.0,Benzinga's Top #PreMarket Gainers,2014-07-31 08:07:00-04:00,HOLX,positive
624231.0,July 30 After Hours Movers,2014-07-30 18:16:00-04:00,HOLX,neutral
624232.0,"Hologic, Inc. Reports Q3 EPS of $0.37 vs $0.34 Est; Revenue of $632.60M vs $621.89M Est",2014-07-30 16:01:00-04:00,HOLX,neutral
624233.0,"BTIG Research Downgrades Hologic, Inc. to Neutral",2014-07-07 08:05:00-04:00,HOLX,neutral
624234.0,"Standpoint Research Downgrades Hologic, Inc. to Hold",2014-07-02 12:17:00-04:00,HOLX,neutral
624235.0,Hologic Announces Positive Results on 3D Mammography Study Published in JAMA ,2014-06-24 21:48:00-04:00,HOLX,positive
624236.0,Hologic Names Robert McMahon CFO,2014-05-13 08:01:00-04:00,HOLX,neutral
624237.0,Hologic Reports Q2 Earnings; Net Loss Improves,2014-05-01 08:09:00-04:00,HOLX,positive
624238.0,"Stocks To Watch For May 1, 2014",2014-05-01 04:43:00-04:00,HOLX,neutral
624239.0,"Hologic, Inc. Reports Q2 EPS of $0.37 vs $0.33 Est; Revenue of $625.0M vs $609.25M Est",2014-04-30 16:01:00-04:00,HOLX,neutral
624240.0,BTIG Notes 4 Reasons To Buy Hologic,2014-04-25 06:56:00-04:00,HOLX,neutral
624241.0,Benzinga's Top Initiations,2014-04-24 09:40:00-04:00,HOLX,positive
624242.0,"BTIG Research Initiates Coverage on Hologic, Inc. at Buy, Announces $26.00 PT",2014-04-24 08:59:00-04:00,HOLX,neutral
624243.0,Hologic Highlights Healthcare Solutions for Women at ACOG April 26-30,2014-04-23 08:39:00-04:00,HOLX,positive
624244.0,Hologic's NovaSure System Reaches 2M Milestone Mark,2014-04-22 16:18:00-04:00,HOLX,positive
624245.0,Top 40 Upcoming Earnings Releases  ,2014-04-11 16:08:00-04:00,HOLX,positive
624246.0,"Hologic Could See $27.9M in Additional Annual Revenue, Piper Jaffray Says",2014-03-31 15:25:00-04:00,HOLX,neutral
624247.0,Hologic Appoints Compton COO; CFO Muir to Retire,2014-03-14 07:58:00-04:00,HOLX,neutral
624248.0,Hologic Announces Application Submitted for Breast Tomosynthesis Accepted for 3 Category I CPT Codes,2014-03-06 07:09:00-05:00,HOLX,positive
624249.0,"Hologic Announces Positive Results of Feb. AMA CPT Editorial Panel Meeting, Says Application Accepted",2014-03-06 07:07:00-05:00,HOLX,positive
624250.0,"13F from Relational Investors Shows New Stake in RPM Int'l, Liquidated Position in Vitamin Shoppe, Raised Stake in Hologic",2014-02-14 16:24:00-05:00,HOLX,positive
624251.0,13F from Icahn Shows New ~34M Share Stake in Hologic,2014-02-14 16:19:00-05:00,HOLX,positive
624252.0,An Investor's Guide to Hot In Vitro Diagnostics Market,2014-02-12 11:04:00-05:00,HOLX,neutral
624253.0,"#PreMarket Primer for Tuesday, February 4: Will The Plunge Continue?",2014-02-04 06:58:00-05:00,HOLX,neutral
624254.0,Hologic Jumps After Q1 Earnings Beat,2014-02-03 16:45:00-05:00,HOLX,neutral
624255.0,"Hologic, Inc. Sees Q2 EPS $0.32-0.34 vs $0.33 Est; Sees Sales $605.0M-615.0M vs $606.40M Est",2014-02-03 16:04:00-05:00,HOLX,neutral
624256.0,"Hologic, Inc. Raises FY2014 EPS Guidance from $1.32-1.38 to $1.34-1.38 vs $1.36 Est",2014-02-03 16:04:00-05:00,HOLX,neutral
624257.0,"Hologic, Inc. Reports Q1 EPS of $(0.02) Which May Not Compare $0.31 Est; Revenue of $612.40M Which May Not Compare $609.65M Est",2014-02-03 16:02:00-05:00,HOLX,neutral
624258.0,"Earnings Scheduled For February 3, 2014",2014-02-03 04:23:00-05:00,HOLX,neutral
624259.0,"ISI Group Downgrades Hologic, Inc. to Buy, Lowers to $(aN)",2014-01-22 07:51:00-05:00,HOLX,negative
624260.0,Morgan Stanley Downgrades Hologic on Challenging Near-term Upside,2014-01-06 15:15:00-05:00,HOLX,positive
624261.0,"Morgan Stanley Downgrades Hologic, Inc. to Equal-weight, Removes $22.00 PT",2014-01-06 06:56:00-05:00,HOLX,neutral
624262.0,13D Filing from Relational Investors on Hologic Shows 7.3% Stake,2013-12-20 17:25:00-05:00,HOLX,neutral
624263.0,"US Says Carl Icahn, Hologic Potential Deal Approved; FTC Doesn't Make Clear What Type of Transaction Approved",2013-12-13 09:40:00-05:00,HOLX,positive
624264.0,"Carl Icahn Acquires 30,629,879 Shares of Hologic, Now Reported on Form 4",2013-12-12 17:25:00-05:00,HOLX,positive
624265.0,Carl Icahn Reports 12.51% Stake in Hologic; Acquired Stake Through 30.6M Share Call Option Excercise,2013-12-12 17:24:00-05:00,HOLX,positive
624266.0,Carl Icahn Tweet: 'Optimistic re changes at HOLOGIC. Two of our reps have joined the board and we welcome new CEO Steve MacMillan',2013-12-09 08:46:00-05:00,HOLX,positive
624267.0,"Carl Icahn Files Amended 13D on Hologic, Discloses This Morning's Mgmt News",2013-12-09 08:45:00-05:00,HOLX,neutral
624268.0,UPDATE: Hologic Says Carl Icahn Agreed to Vote for Hologic's Slate of Directors,2013-12-09 08:16:00-05:00,HOLX,positive
624269.0,"Hologic Names Jonathan Christodoro, Samuel Merksamer to Board, Engaged Burton Drayer as Scientific Adviser",2013-12-09 08:16:00-05:00,HOLX,positive
624270.0,"Hologic Names Stephen MacMillan Pres, CEO",2013-12-09 08:02:00-05:00,HOLX,neutral
624271.0,Cowen Downgrades Hologic,2013-12-02 13:03:00-05:00,HOLX,neutral
624272.0,"Cowen & Company Downgrades Hologic, Inc. to Market Perform, Lowers PT to $24.00",2013-12-02 07:44:00-05:00,HOLX,negative
624273.0,Hologic Files Automatic Mixed Securities Shelf,2013-11-26 07:28:00-05:00,HOLX,positive
624274.0,"Market Wrap For November 21: Dow Re-Claims 16,000 level On Positive Job Data",2013-11-21 16:40:00-05:00,HOLX,positive
624275.0,Hologic Announced Stockholder Rights Plan,2013-11-21 13:34:00-05:00,HOLX,neutral
624276.0,Carl Icahn Tweet: 'Disclosed aprx. 34 million share position in HOLOGIC. May have convos re enhancing shareholder value',2013-11-21 09:17:00-05:00,HOLX,positive
624277.0,Benzinga's Top #PreMarket Gainers,2013-11-21 08:13:00-05:00,HOLX,positive
624278.0,Hologic Adopts One-Year Stockholder Rights Plan,2013-11-21 08:00:00-05:00,HOLX,positive
624279.0,"13D Filing on Hologic from Carl Icahn Just Out, Shows 12.63% Stake",2013-11-21 07:56:00-05:00,HOLX,neutral
624280.0,Mid-Afternoon Market Update: Markets in the Red as American Airlines/US Airways Merger Approved,2013-11-12 16:09:00-05:00,HOLX,positive
624281.0,Mid-Day Market Update: Hologic Shares Drop On Weak Outlook; Dish Spikes Higher,2013-11-12 12:26:00-05:00,HOLX,negative
624282.0,UPDATE: Citigroup Reiterates on Hologic on Near-Term Weakness,2013-11-12 11:35:00-05:00,HOLX,negative
624283.0,UPDATE: SunTrust Robinson Humphrey Reiterates on Hologic as Deterioration Story Gains Momentum,2013-11-12 09:41:00-05:00,HOLX,positive
624284.0,UPDATE: Canaccord Genuity Downgrades Hologic on Negative Outlook,2013-11-12 09:09:00-05:00,HOLX,negative
624285.0,Benzinga's Top #PreMarket Losers,2013-11-12 08:22:00-05:00,HOLX,negative
624286.0,"Craig-Hallum Downgrades Hologic, Inc. to Hold, Lowers PT to $21.00",2013-11-12 08:17:00-05:00,HOLX,negative
624287.0,Benzinga's Top Downgrades,2013-11-12 07:40:00-05:00,HOLX,positive
624288.0,"William Blair Downgrades Hologic, Inc. to Market Perform",2013-11-12 07:36:00-05:00,HOLX,neutral
624289.0,"RBC Capital Downgrades Hologic, Inc. to Sector Perform, Lowers PT to $21.00",2013-11-12 07:35:00-05:00,HOLX,negative
624290.0,"#PreMarket Primer: Tuesday, November 12: China's Economic Blueprints Anxiously Awaited",2013-11-12 06:55:00-05:00,HOLX,negative
624291.0,"Stocks To Watch For November 12, 2013",2013-11-12 06:26:00-05:00,HOLX,neutral
624292.0,"Canaccord Genuity Downgrades Hologic, Inc. to Hold, Lowers to $19.00",2013-11-12 06:17:00-05:00,HOLX,negative
624293.0,"From Hologic Call: Believes Most Recent Forecast is 'More Realistic,' Says Will Reach Leverage Goal in FY17",2013-11-11 17:39:00-05:00,HOLX,neutral
624294.0,"From Hologic Call: Expecting Low-Single Digit Percentage Growth in 2015, Sees Mid-Single Digit Growth After FY15",2013-11-11 17:26:00-05:00,HOLX,positive
624295.0,From Hologic Call: Expecting Tailwinds in FY15,2013-11-11 17:21:00-05:00,HOLX,neutral
624296.0,From Hologic Call: Mgmt Evaluating Each of Its Business,2013-11-11 17:13:00-05:00,HOLX,neutral
624297.0,From Hologic Call: Expecting Secular Headwinds in 2014,2013-11-11 17:08:00-05:00,HOLX,neutral
624298.0,Hologic Q4 Earnings Call Beginning,2013-11-11 17:04:00-05:00,HOLX,neutral
624299.0,"Hologic Falls After Q4 Beat, Weak Guidance",2013-11-11 16:58:00-05:00,HOLX,negative
624300.0,Hologic Reports $250M Buyback Plan,2013-11-11 16:13:00-05:00,HOLX,neutral
624301.0,"Hologic, Inc. Sees Q1 EPS $0.30-0.31 vs $0.40 Est; Sees Sales $600.0M-610.0M vs $642.0M Est",2013-11-11 16:08:00-05:00,HOLX,neutral
624302.0,"Hologic, Inc. Reports Q4 EPS of $0.39 vs $0.37 Est; Revenue of $622.10M vs $624.42M Est",2013-11-11 16:05:00-05:00,HOLX,neutral
624303.0,Hologic Announces $250M Stock Buyback Program ,2013-11-11 16:04:00-05:00,HOLX,neutral
624304.0,"Earnings Scheduled For November 11, 2013",2013-11-11 04:46:00-05:00,HOLX,neutral
624305.0,Hologic Says FDA Has Approved Aptima HPV 16 18/45 Genotype Assay,2013-11-07 16:34:00-05:00,HOLX,positive
624306.0,UPDATE: Citigroup Downgrades Hologic on More Balanced Risk/Reward Profile,2013-10-16 10:41:00-04:00,HOLX,neutral
624307.0,"Citigroup Downgrades Hologic, Inc. to Neutral",2013-10-16 07:00:00-04:00,HOLX,neutral
624308.0,"Needham Initiates Coverage on Hologic, Inc. at Buy, Announces $26.00 PT",2013-10-02 08:39:00-04:00,HOLX,neutral
624309.0,UPDATE: ISI Group Upgrades Hologic as Shares Approach a Tipping Point,2013-09-24 10:56:00-04:00,HOLX,positive
624310.0,"ISI Group Upgrades Hologic, Inc. to Strong Buy, Raises PT to $25.50",2013-09-24 07:10:00-04:00,HOLX,positive
624311.0,"Raymond James Downgrades Hologic, Inc. to Market Perform, Removes $23.00 PT",2013-09-11 09:13:00-04:00,HOLX,neutral
624312.0,"Benzinga Market Primer: Tuesday, August 6: Futures Flat Ahead Of Fed Speak",2013-08-06 06:39:00-04:00,HOLX,neutral
624313.0,Hologic Reports Q3 Loss; Cuts Full-Year EPS Guidance (HOLX),2013-08-05 17:40:00-04:00,HOLX,negative
624314.0,"Hologic, Inc. Sees Q4 EPS $0.36-0.37 vs $0.44 Est; Sees Sales $615.0M-625.0M vs $653.40M Est",2013-08-05 16:04:00-04:00,HOLX,neutral
624315.0,"Hologic, Inc. Lowers FY2013 EPS Guidance from $1.54-1.56 to $1.46-1.47 vs $1.54 Est; Sees Sales $2.05B-2.52B",2013-08-05 16:03:00-04:00,HOLX,negative
624316.0,"Hologic, Inc. Reports Q3 EPS of $0.38 vs $0.37 Est; Revenue of $626.10M vs $626.84M Est",2013-08-05 16:01:00-04:00,HOLX,neutral
624317.0,"Earnings Expected After the Close Aug. 5th: Hillenbrand, Hologic, Kindred, McDermott, Plains All American, Skilled Healthcare",2013-08-05 15:49:00-04:00,HOLX,neutral
624318.0,"Benzinga Market Primer: Monday, August 5: Futures Flat On Relaxed China Fears, Emerging Market Rebound",2013-08-05 06:30:00-04:00,HOLX,positive
624319.0,FDA Approves Aptima HPV Assay For Use On Hologic's Panther System,2013-07-23 16:02:00-04:00,HOLX,positive
624320.0,Hologic Appoints Jack W. Cumming President and Chief Executive Officer,2013-07-18 16:02:00-04:00,HOLX,neutral
624321.0,UPDATE: Piper Jaffray Downgrades Hologic Following STD Channel Checks,2013-07-17 08:28:00-04:00,HOLX,neutral
624322.0,Benzinga's Top Downgrades,2013-07-17 07:42:00-04:00,HOLX,positive
624323.0,"Piper Jaffray Downgrades Hologic, Inc. to Neutral, Lowers PT to $21.00",2013-07-17 06:42:00-04:00,HOLX,negative
624324.0,Hologic Shares Turn Positive Following News of Alliance with Quest Diagnosstics,2013-06-06 13:25:00-04:00,HOLX,positive
624325.0,UPDATE: Bank of America Lowers PO on Hologic Due to Updated Valuation,2013-06-04 10:35:00-04:00,HOLX,negative
624326.0,"Bank of America Maintains Neutral on Hologic, Inc., Lowers PO to $21.00",2013-06-04 08:48:00-04:00,HOLX,negative
624327.0,Hologic Investors Shrug at News 3D Mammography Significantly Reduced Recall Rates,2013-05-23 10:49:00-04:00,HOLX,neutral
624328.0,Traders in Hologic Responding to 1.09M Share Block Trade Crosses at $20.85/Share; Stock Now Down 1.6%,2013-05-22 12:29:00-04:00,HOLX,negative
624329.0,UPDATE: Hologic Receives FDA Approval for a New Low-dose 3D Mammography (Breast Tomosynthesis) Solution for Breast Cancer Screening,2013-05-21 08:19:00-04:00,HOLX,neutral
624330.0,Hologic Wins FDA Approval for New Low-Dose 3D Mammography Solution,2013-05-21 08:15:00-04:00,HOLX,positive
624331.0,Hologic Appoints Scott Garrett to Board of Directors,2013-05-08 16:03:00-04:00,HOLX,neutral
624332.0,"(OPTIONS): Hologic December ATM 20 Puts Trade 5,274 Times Over an OI of 10",2013-05-07 11:15:00-04:00,HOLX,neutral
624333.0,"Raymond James Downgrades Hologic, Inc. to Outperform, Lowers PT to $23.00",2013-05-07 08:28:00-04:00,HOLX,negative
624334.0,Benzinga's Top Downgrades,2013-05-07 07:45:00-04:00,HOLX,positive
624335.0,"ISI Group Downgrades Hologic, Inc. to Buy, Lowers PT to $24.00",2013-05-07 07:40:00-04:00,HOLX,negative
624336.0,"Hologic, Inc. Sees FY2013 EPS $1.54-1.56 vs $1.58 Est; Sees Sales $2.53B-2.55B vs $2.62B Est",2013-05-06 16:05:00-04:00,HOLX,neutral
624337.0,"Hologic, Inc. Sees Q3 Sales $625.0M-630.0M vs $655.40M Est",2013-05-06 16:02:00-04:00,HOLX,neutral
624338.0,"Hologic, Inc. Reports Q2 EPS of $0.35 vs $0.34 Est; Revenue of $619.10M",2013-05-06 16:01:00-04:00,HOLX,neutral
624339.0,Hologic Says Study Supports Use of Breast Tomosynthesis in Cancer Screening in Practices Using Double Reads,2013-04-16 16:09:00-04:00,HOLX,negative
624340.0,"Stifel Nicolaus Initiates Coverage on Hologic, Inc. at Hold",2013-04-10 07:44:00-04:00,HOLX,neutral
624341.0,"Stifel Nicolaus Initiates Coverage on Hologic, Inc. at Hold",2013-04-09 16:44:00-04:00,HOLX,neutral
624342.0,"Unusual Options Activity: Hologic April 22.00 Puts Trade 1,970 Times Against an Open Interest of 45",2013-04-05 11:13:00-04:00,HOLX,positive
624343.0,Hologic's APTIMA HPV Assay and APTIMA HPV 16 18/45 Genotype Assay Receive Canadian Regulatory Approval,2013-04-04 16:33:00-04:00,HOLX,positive
624344.0,Hologic Announces Completion of Loan Repricing,2013-03-20 16:01:00-04:00,HOLX,neutral
624345.0,"Akamai, Murphy Oil and Other Stocks Insiders Are Buying",2013-02-16 13:57:00-05:00,HOLX,neutral
624346.0,UPDATE: Bank of America Downgrades Hologic to Neutral on Valuation,2013-02-06 07:32:00-05:00,HOLX,neutral
624347.0,"Bank of America Downgrades Hologic, Inc. to Neutral, Raises PO to $24.00",2013-02-06 06:54:00-05:00,HOLX,negative
624348.0,UPDATE: ISI Group Raises PT to $27 on Hologic Following Guidance Raise,2013-02-05 14:29:00-05:00,HOLX,neutral
624349.0,"ISI Group Maintains Strong Buy on Hologic, Inc., Raises PT to $27.00",2013-02-05 08:57:00-05:00,HOLX,positive
624350.0,"Hologic, Inc. Raises FY2013 EPS Guidance from $1.56-1.58 to $1.58-1.60 vs $1.58 Est",2013-02-04 16:04:00-05:00,HOLX,neutral
624351.0,"Hologic, Inc. Sees Q1 Sales $635.0M-640.0M vs $650.30M Est",2013-02-04 16:03:00-05:00,HOLX,neutral
624352.0,"Hologic, Inc. Reports Q1 EPS of $0.38, Inline",2013-02-04 16:02:00-05:00,HOLX,neutral
624353.0,"Barrington Research Maintains Outperform on Hologic, Inc., Raises PT to $26.00",2013-01-30 06:56:00-05:00,HOLX,neutral
624354.0,Hologic Reports Organizational Changes to Diagnostics Unit,2013-01-22 16:11:00-05:00,HOLX,neutral
624355.0,A Peek Into The Market Before The Trading Starts,2013-01-14 07:14:00-05:00,HOLX,neutral
624356.0,Hologic Receives FDA Clearance for APTIMA Trichomonas for Use on PANTHER System ,2013-01-14 06:13:00-05:00,HOLX,neutral
624357.0,"Mid-Morning Market Update: Markets Rising, Herbalife Boosts on Dan Loeb Stake",2013-01-09 10:21:00-05:00,HOLX,positive
624358.0,"Hologic to Sell LIFECODES to Immucor for $85M in Cash, $10M Contingent Payment",2013-01-03 17:07:00-05:00,HOLX,neutral
624359.0,KV Pharma Gets Court Approval of Hologic Settlement,2012-12-28 12:46:00-05:00,HOLX,positive
624360.0,From Earlier: Becton Dickinson Announce Settlement Pact with Gen-Probe,2012-12-04 07:26:00-05:00,HOLX,neutral
624361.0,Hologic Guides FY Revenue $2.61-2.64B vs $2.68B Est,2012-11-12 16:05:00-05:00,HOLX,neutral
624362.0,Hologic Guides Q1 EPS $0.37 vs $0.40 Est; Guides FY EPS $1.56-1.58 vs $1.64 Est; Guides Q1 Revenue $640-645M vs $661.3M Est,2012-11-12 16:04:00-05:00,HOLX,neutral
624363.0,Hologic Reports Q4 EPS $0.37 vs $0.37 Est; Revenues $588.5M vs $581.62M Est,2012-11-12 16:03:00-05:00,HOLX,neutral
624364.0,Earnings Preview: Hologic ,2012-11-12 05:58:00-05:00,HOLX,neutral
624365.0,"Citigroup Maintains Hologic at Buy, Raises PT from $22 to $25",2012-10-16 10:54:00-04:00,HOLX,neutral
624366.0,Hologic Announces FDA Approval of APTIMA HPV 16 18/45 Genotype Assay ,2012-10-16 06:23:00-04:00,HOLX,positive
624367.0,"UPDATE: Morgan Stanley Resumes Coverage on Hologic with Overweight Rating, $26 PT",2012-10-03 09:19:00-04:00,HOLX,negative
624368.0,"Morgan Stanley Resumes Coverage on Hologic at Overweight, Announces PT of $26",2012-10-03 05:53:00-04:00,HOLX,negative
624369.0,"UPDATE: Canaccord Genuity Reiterates Buy Rating, Raises PT on Hologic",2012-09-24 12:15:00-04:00,HOLX,neutral
624370.0,"Canaccord Maintains Hologic at Buy, Raises PT from $23 to $27",2012-09-24 07:13:00-04:00,HOLX,neutral
624371.0,"Jefferies & Company Maintains Hologic at Buy, Raises PT from $24 to $26",2012-09-21 06:59:00-04:00,HOLX,neutral
624372.0,UPDATE: Cantor Fitzgerald Reiterates Hold on Hologic; Raises PT from $20 to $21,2012-08-07 10:01:00-04:00,HOLX,neutral
624373.0,"Cantor Fitzgerald Maintains Hologic at Hold, Raises PT from $20 to $21",2012-08-07 07:23:00-04:00,HOLX,neutral
624374.0,Raymond James Upgrades Hologic from Outperform to Strong Buy,2012-08-03 07:37:00-04:00,HOLX,positive
624375.0,Hologic Sees Purchase of Gen-Probe Adding $0.20 to Earnings,2012-08-01 09:04:00-04:00,HOLX,neutral
624376.0,Hologic Completes Acquisition Of Gen-Probe ,2012-08-01 09:01:00-04:00,HOLX,neutral
624377.0,Gen-Probe Receives Stockholder Approval For Proposed Merger With Hologic,2012-07-31 16:29:00-04:00,HOLX,positive
624378.0,UPDATE: Canaccord Lowers PT on Hologic from $24 to $23,2012-07-31 09:58:00-04:00,HOLX,negative
624379.0,Dougherty & Company Upgrades Hologic from Neutral to Buy,2012-07-31 09:29:00-04:00,HOLX,neutral
624380.0,"Canaccord Maintains Hologic at Buy, Lowers PT from $24 to $23",2012-07-31 06:42:00-04:00,HOLX,negative
624381.0,Hologic Guides Q3 EPS $0.35-0.36 vs $0.36 Est; Guides Q4 Revenue $485M vs $495.5M Est,2012-07-30 16:03:00-04:00,HOLX,neutral
624382.0,Hologic Reports Q3 EPS $0.35 vs $0.34 Est; Revenues $470.2M vs $476.23M Est,2012-07-30 16:02:00-04:00,HOLX,neutral
624383.0,"Barclays Maintains Hologic at Equal-weight, Raises PT from $20 to $21",2012-07-23 12:35:00-04:00,HOLX,neutral
624384.0,Hologic Announces Pricing Of Financing In Connection With Acquisition Of Gen-Probe ,2012-07-19 11:18:00-04:00,HOLX,neutral
624385.0,Hologic and Gen-Probe Announce Clearance from German Federal Cartel Office for Hologic's Acquisition of Gen-Probe ,2012-07-17 06:34:00-04:00,HOLX,neutral
624386.0,UPDATE: Hologic Sees Q3 Non-GAAP EPS of $0.34-0.35 vs $0.34 Est; Revenues $470M vs $490.92M Est,2012-07-11 16:10:00-04:00,HOLX,neutral
624387.0,Hologic And Gen-Probe Provide Update On Pending Transaction ,2012-07-11 16:02:00-04:00,HOLX,neutral
624388.0,Hologic Announces $750 Million Note Offerinng,2012-07-11 16:01:00-04:00,HOLX,neutral
624389.0,"Option Alert: Hologic August 16 Put; Block Trade: 1,950 Contracts @$0.20; Currently $18.31",2012-07-10 10:15:00-04:00,HOLX,negative
624390.0,"UPDATE: ISI Group Initiates Hologic with Overweight, $21 PT on Product Momentum  ",2012-07-10 09:00:00-04:00,HOLX,negative
624391.0,"ISI Group Initiates Coverage on Hologic at Overweight, Announces PT of $21",2012-07-10 06:07:00-04:00,HOLX,negative
624392.0,"Option Alert: Hologic September 22 Call; Block Trade: 2,626 Contracts; Currently $17.31",2012-06-25 10:26:00-04:00,HOLX,negative
624393.0,Hologic and Gen-Probe Announce Expiration of Hart-Scott-Rodino Act Waiting Period ,2012-06-19 06:32:00-04:00,HOLX,neutral
624394.0,"Benzinga's Top Upgrades with Color for May 14, 2012",2012-05-14 12:52:00-04:00,HOLX,positive
624395.0,UPDATE: J.P. Morgan Upgrades Hologic; Raises PT,2012-05-14 08:15:00-04:00,HOLX,neutral
624396.0,"JP Morgan Upgrades Hologic from Neutral to Overweight, Raises PT from $20 to $22",2012-05-14 05:50:00-04:00,HOLX,neutral
624397.0,"Benzinga's Top Downgrades With Color for May 1, 2012",2012-05-01 10:02:00-04:00,HOLX,positive
624398.0,UPDATE: Dougherty Downgrades Hologic; Lowers PT,2012-05-01 09:00:00-04:00,HOLX,negative
624399.0,UPDATE: Wunderlich Securities Raises PT to $18 on Conceptus; Hologic Settlement  ,2012-05-01 08:13:00-04:00,HOLX,positive
624400.0,"Dougherty & Company Downgrades Hologic from Buy to Neutral, Lowers PT from $26 to $20",2012-05-01 07:51:00-04:00,HOLX,negative
624401.0,"Cantor Fitzgerald Maintains Hologic at Hold, Raises PT from $18 to $20",2012-05-01 06:54:00-04:00,HOLX,neutral
624402.0,"Benzinga's M&A Chatter for Monday April 30, 2012",2012-04-30 17:11:00-04:00,HOLX,neutral
624403.0,Hologic Splashes Out $3.72 Billion for Gen-Probe,2012-04-30 11:37:00-04:00,HOLX,neutral
624404.0,"Morning Social Media Outlook for Monday April 30 (GPRO, HOLX, OME, NLY)",2012-04-30 10:55:00-04:00,HOLX,neutral
624405.0,"Financial Breakfast: Morning News Summary for April 30, 2012",2012-04-30 07:30:00-04:00,HOLX,neutral
624406.0,A Peek Into The Market Before The Trading Starts,2012-04-30 07:21:00-04:00,HOLX,neutral
624407.0,Conceptus(R) Announces Settlement of Patent Infringement Lawsuit With Hologic; Raises 2012 Financial Guidance,2012-04-30 06:46:00-04:00,HOLX,negative
624408.0,Hologic Reports Q2 EPS $0.33 vs $0.33 Est; Revenues $471.2M vs $474M Est,2012-04-30 06:38:00-04:00,HOLX,neutral
624409.0,Hologic to Acquire Gen-Probe for $82.75/Share,2012-04-30 06:30:00-04:00,HOLX,neutral
624410.0,A Cup's Left Side Is No Place For Panic - IBD,2012-04-27 16:54:00-04:00,HOLX,negative
624411.0,UPDATE: Bank of America Initiates Coverage on Hologic,2012-04-04 07:27:00-04:00,HOLX,neutral
624412.0,"Bank of America Initiates Coverage on Hologic at Buy, Announces PO of $26",2012-04-04 06:08:00-04:00,HOLX,negative
624413.0,UPDATE: Dougherty & Company Upgrades Hologic to Buy,2012-03-05 15:03:00-05:00,HOLX,neutral
624414.0,"Dougherty & Company Upgrades Hologic from Neutral to Buy, Maintains PT at $26",2012-03-05 12:52:00-05:00,HOLX,neutral
624415.0,UPDATE: Dougherty & Company Upgrades Hologic to Buy,2012-03-01 14:04:00-05:00,HOLX,neutral
624416.0,"Dougherty & Company Upgrades Hologic from Neutral  to Buy, Raises PT from $20 to $26",2012-03-01 12:04:00-05:00,HOLX,neutral
624417.0,From Earlier: Hologic Announces Exchange Transaction to Retire 2.00% Convertible Senior Notes Due 2037  ,2012-02-29 07:26:00-05:00,HOLX,neutral
624418.0,"Benzinga's M&A Chatter for Tuesday February 7, 2012",2012-02-07 18:52:00-05:00,HOLX,neutral
624419.0,Hologic Trading 0.2% Lower on Heavy Volume; Currently at $20.74,2012-02-07 10:31:00-05:00,HOLX,negative
624420.0,Hearing Takeover Chatter in Hologic; Siemens Rumored Buyer at $32,2012-02-07 10:29:00-05:00,HOLX,neutral
624421.0,Hologic up 5.8% on Strong Earnings and Guidance ,2012-01-31 10:38:00-05:00,HOLX,positive
624422.0,UPDATE: Canaccord Raises Target to $24 on Hologic,2012-01-31 09:29:00-05:00,HOLX,neutral
624423.0,Morgan Stanley: Improved Sensitivity Will Change the Debate on Hologic,2012-01-31 08:23:00-05:00,HOLX,positive
624424.0,Hologic Pops on Q1 Earnings Beat,2012-01-30 16:16:00-05:00,HOLX,neutral
624425.0,Hologic Guides Q2 EPS $0.33 vs $0.33 Est; Revenues $470-475M vs $471.10M Est,2012-01-30 16:04:00-05:00,HOLX,neutral
624426.0,Hologic Reports Q1 EPS $0.34 vs $0.32 Est; Revenues $472.7M vs $466.51M Est	 			,2012-01-30 16:02:00-05:00,HOLX,neutral
624427.0,UPDATE: Stifel Nicolaus Downgrades Hologic to Hold,2012-01-26 09:04:00-05:00,HOLX,neutral
624428.0,"Stifel Nicolaus Downgrades EFSC, GPN, HOLX, WSBC to Hold",2012-01-26 08:09:00-05:00,HOLX,neutral
624429.0,Hologic Spikes Higher on Heavy Volume,2012-01-09 13:32:00-05:00,HOLX,neutral
624430.0,Hologic Announces Denial of Conceptus' Request for Injunction in Patent Infringement Suit,2012-01-09 13:30:00-05:00,HOLX,negative
624431.0,Notable Put Options Activity in Hologic,2012-01-04 15:30:00-05:00,HOLX,neutral
624432.0,UPDATE: JP Morgan Downgrades Hologic to Neutral ,2012-01-03 12:17:00-05:00,HOLX,positive
624433.0,UPDATE: Morgan Stanley Upgrades Hologic to Overweight,2012-01-03 07:00:00-05:00,HOLX,negative
624434.0,JP Morgan Downgrades Hologic to Neutral ,2012-01-03 06:48:00-05:00,HOLX,positive
624435.0,Morgan Stanley Upgrades Hologic to Overweight ,2012-01-03 06:05:00-05:00,HOLX,negative
624436.0,"End-of-Day Market Summary for December 15, 2011",2011-12-15 16:29:00-05:00,HOLX,neutral
624437.0,FDA Approves Hologic's Cervista High Throughput Automation System for Cervical Cancer Screening,2011-12-15 16:11:00-05:00,HOLX,negative
624438.0,"Piper Jaffray Reiterates Overweight, $26 Target on Hologic ",2011-12-08 07:43:00-05:00,HOLX,negative
624439.0,Hologic Spiking Lower on Heavy Volume,2011-12-01 13:06:00-05:00,HOLX,negative
624440.0,"Citigroup Reiterates Buy, $21 on Hologic ",2011-12-01 07:18:00-05:00,HOLX,neutral
624441.0,Morgan Stanley Maintains Overweight on Hologic ,2011-11-30 07:21:00-05:00,HOLX,negative
624442.0,Hologic Jumps on Q4 Earnings Beat,2011-11-07 16:50:00-05:00,HOLX,neutral
624443.0,Hologic Inc Reports Q4 EPS $0.34 vs $0.33 Est; Revenues $467M vs $457.43M Est			,2011-11-07 16:05:00-05:00,HOLX,neutral
624444.0,Brean Murray Carret & Co Maintains Hold Rating on Hologic ,2011-11-07 09:42:00-05:00,HOLX,neutral
624445.0,UPDATE: Stifel Nicolaus Lowers PT on Hologic to $20,2011-11-03 09:36:00-04:00,HOLX,negative
624446.0,Benzinga's Top Downgrades,2011-10-27 07:59:00-04:00,HOLX,positive
624447.0,Hearing Hologic Downgraded to Neutral at Ticonderoga,2011-10-27 06:57:00-04:00,HOLX,neutral
624448.0,Hologic Announces FDA Clears Two New Hologic MRI Coils,2011-10-25 16:46:00-04:00,HOLX,positive
624449.0,Genetic Technologies Executes Settlement and License Agreement with Hologic ,2011-10-19 10:08:00-04:00,HOLX,positive
624450.0,FDA Clears Hologic's Specimen Radiography System ,2011-10-18 14:01:00-04:00,HOLX,positive
624451.0,Hologic Announces Jury Verdict in Patent Infringement Suit; Will Not Impact Financial Results ,2011-10-18 13:32:00-04:00,HOLX,negative
624452.0,Hologic Spiking Lower on Heavy Volume Following Earlier Wellpoint Report,2011-10-12 11:45:00-04:00,HOLX,negative
624453.0,Wellpoint Says Hologic's Digital Breast Tomosynthesis is Considered Investigational and Not Medically Necessary,2011-10-12 11:24:00-04:00,HOLX,neutral
624454.0,Notable Call Options Activity in Hologic,2011-09-28 13:46:00-04:00,HOLX,neutral
624455.0,Notable Call Options Activity in Hologic,2011-09-28 13:38:00-04:00,HOLX,neutral
624456.0,Piper Jaffray Overweight on Hologic,2011-09-21 07:51:00-04:00,HOLX,negative
624457.0,Notable Put Options Activity in Hologic,2011-08-24 14:57:00-04:00,HOLX,neutral
624458.0,J.P. Morgan Decreases PT Of HOLX From $24 To $20,2011-08-02 09:04:00-04:00,HOLX,neutral
624459.0,Piper Jaffray Increases Revenue Estimates Of Hologic For FY11 And FY12,2011-08-02 08:27:00-04:00,HOLX,neutral
624460.0,Citi Maintains $26 Price Target On Holigic,2011-08-02 08:21:00-04:00,HOLX,neutral
624461.0,Goldman Sachs Lowers PT On Hologic To $23,2011-08-02 07:27:00-04:00,HOLX,negative
624463.0,JP Morgan Lowers PT on Hologic To $20,2011-08-02 06:33:00-04:00,HOLX,positive
624464.0,Hologic Reports Q3 EPS $0.32 vs $0.32 Est; Revenues $451.1M vs $446.99M Est			,2011-08-01 16:03:00-04:00,HOLX,neutral
624465.0,Earnings Scheduled For August 1,2011-08-01 03:31:00-04:00,HOLX,neutral
624466.0,Wednesday's Put/Call Ratio Leaders,2011-06-15 12:32:00-04:00,HOLX,neutral
624467.0,"Puts Purchased on Hologic, Inc.",2011-06-15 11:59:00-04:00,HOLX,neutral
624468.0,Morgan Stanley Maintains Equal-Weight on Hologic,2011-06-02 09:45:00-04:00,HOLX,neutral
624469.0,Piper Jaffray Reports on Hologic ,2011-06-02 07:52:00-04:00,HOLX,neutral
624470.0,Hologic Acquires TCT International Co for $135M,2011-06-01 16:02:00-04:00,HOLX,neutral
624471.0,Piper Jaffray Raises PT To $26 On Hologic,2011-05-03 07:32:00-04:00,HOLX,neutral
624472.0,Goldman Sachs Raises HOLX Target From $25 To $26,2011-05-03 07:18:00-04:00,HOLX,neutral
624473.0,Morgan Stanley Confirms Stable Trends On Hologic (HOLX),2011-05-03 06:16:00-04:00,HOLX,positive
624474.0,Piper Jaffray Raises PT On Hologic To $26,2011-05-03 05:59:00-04:00,HOLX,neutral
624475.0,Jefferies Raises PT on Hologic To $26,2011-05-03 05:45:00-04:00,HOLX,neutral
624476.0,Hologic Guides FY 2011 EPS $1.24-$1.26 vs. $1.23 Estimate (HOLX),2011-05-02 16:03:00-04:00,HOLX,neutral
624477.0,Hologic Reports EPS of $0.30 vs. $0.28 Estimate; Revenues $438.7M vs. $433.21M Estimate (HOLX),2011-05-02 16:02:00-04:00,HOLX,neutral
624478.0,Hologic Receives FDA Clearance to Include Advanced Body Composition Assessment (HOLX),2011-04-20 13:34:00-04:00,HOLX,positive
624479.0,Piper Jaffray Maintains Overweight Rating On HOLX Following Survey,2011-04-19 09:03:00-04:00,HOLX,negative
624480.0,"Fast Money Picks For April 14th (LMT, RIMM, PBR, HOLX)",2011-04-14 20:02:00-04:00,HOLX,neutral
624481.0,JP Morgan Remains Positive On Hologic; Raises PT To $24,2011-04-12 09:26:00-04:00,HOLX,positive
624482.0,JP Morgan Raises PT On Hologic To $24,2011-04-12 07:35:00-04:00,HOLX,positive
624483.0,Piper Jaffray Maintains Overweight on Hologic (HOLX),2011-03-25 08:54:00-04:00,HOLX,negative
624484.0,"Benzinga's Top Downgrades (HOLX, DGW, TAM, BAC)",2011-03-24 08:14:00-04:00,HOLX,positive
624485.0,Hologic Up 2% (HOLX) ,2011-03-21 12:46:00-04:00,HOLX,neutral
624486.0,Stock Market alerts for Friday Mar 18,2011-03-17 17:02:00-04:00,HOLX,neutral
624487.0,UPDATE: Jefferies Raising Price Target On Hologic (HOLX),2011-03-17 07:26:00-04:00,HOLX,neutral
624488.0,Jefferies Raises PT On Hologic To $25,2011-03-17 07:14:00-04:00,HOLX,neutral
624489.0,K-V Pharmaceuticals Adds Another 27% (KV.A),2011-03-08 14:09:00-05:00,HOLX,neutral
624490.0,Citi Maintains Buy on Hologic (HOLX),2011-03-07 08:04:00-05:00,HOLX,neutral
624491.0,Goldman Sachs Has Buy On Hologic (HOLX),2011-03-03 07:36:00-05:00,HOLX,neutral
624492.0,"Goldman Sachs Comments On Healthcare Sector (HOLX, UTHR)",2011-03-03 07:25:00-05:00,HOLX,neutral
624493.0,Hologic Announces Favorable Ruling In Patent Infringement Suit,2011-02-25 14:02:00-05:00,HOLX,neutral
624494.0,"Hologic Announces $135M Acquisition, Jefferies' Outlook Remains Favorable",2011-02-24 09:09:00-05:00,HOLX,positive
624495.0,Jefferies Raises HOLX Estimates,2011-02-14 08:34:00-05:00,HOLX,neutral
624496.0,Hologic Receives FDA Approval for First 3-D Digital Mammography System,2011-02-11 14:33:00-05:00,HOLX,positive
624497.0,FDA Approves Hologic's Makena,2011-02-04 09:12:00-05:00,HOLX,positive
624498.0,Hologic Beats Estimates - Analyst Blog,2011-02-01 12:31:00-05:00,HOLX,neutral
624499.0,Hologic Beats Estimates - Analyst Blog,2011-02-01 12:00:00-05:00,HOLX,neutral
624500.0,Jefferies Raises Its PT on Hologic to $24 (HOLX),2011-02-01 10:45:00-05:00,HOLX,neutral
624501.0,J.P. Morgan Gives Color On Hologic Following Earnings,2011-02-01 08:55:00-05:00,HOLX,neutral
624502.0,Jefferies Raises PT on Hologic To $24,2011-02-01 07:54:00-05:00,HOLX,neutral
624503.0,JP Morgan Raises PT On Hologic To $21,2011-02-01 07:20:00-05:00,HOLX,positive
624504.0,Hologic Losing Ground After Hours (HOLX),2011-01-31 16:18:00-05:00,HOLX,negative
624505.0,Hologic Reports Q1 EPS of $.30 vs. $.30,2011-01-31 16:02:00-05:00,HOLX,neutral
624506.0,Citigroup Upgrades Hologic To Buy,2011-01-20 06:52:00-05:00,HOLX,neutral
624507.0,Piper Jaffray's Top Picks For Medical Diagnostics,2011-01-14 08:47:00-05:00,HOLX,positive
624508.0,Interlace Now Entwined with Hologic - Analyst Blog,2011-01-10 11:31:00-05:00,HOLX,neutral
624509.0,Interlace Now Entwined with Hologic - Analyst Blog,2011-01-10 11:00:00-05:00,HOLX,neutral
624510.0,Prelim Results of CPTS Disappoints - Analyst Blog,2011-01-07 17:06:00-05:00,HOLX,negative
624511.0,Prelim Results of CPTS Disappoints - Analyst Blog,2011-01-07 16:43:00-05:00,HOLX,negative
624512.0,"H&R Block: Analysts' New Targets, Estimates",2010-12-30 09:29:00-05:00,HOLX,negative
624513.0,Piper Jaffray 	Raises Price Target on Hologic (HOLX),2010-12-30 09:17:00-05:00,HOLX,neutral
624514.0,"Hologic Outlook Remains Favorable, Piper Jaffray Reports",2010-12-30 07:54:00-05:00,HOLX,positive
624515.0,Piper Jaffray Raises PT On Hologic,2010-12-30 07:00:00-05:00,HOLX,neutral
624516.0,Myriad Stays Neutral - Analyst Blog,2010-11-30 11:00:00-05:00,HOLX,neutral
624517.0,Myriad Stays Neutral - Analyst Blog,2010-11-30 05:34:00-05:00,HOLX,neutral
624518.0,Good News for Hologic - Analyst Blog,2010-11-26 16:33:00-05:00,HOLX,positive
624519.0,Good News for Hologic - Analyst Blog,2010-11-26 11:00:00-05:00,HOLX,positive
624520.0,Hologic Signs Exclusive Partnership Agreement With SuperSonic Imagine,2010-11-23 16:17:00-05:00,HOLX,positive
624521.0,Hologic Upgraded to Overweight,2010-11-12 08:41:00-05:00,HOLX,negative
624522.0,Citi Reiterates Hold Rating On Hologic (HOLX) ,2010-11-09 12:19:00-05:00,HOLX,neutral
624523.0,Better Than Expected: Hologic F4Q Results,2010-11-09 09:03:00-05:00,HOLX,positive
624524.0,Hologic Beats on Revenues - Analyst Blog,2010-11-09 09:03:00-05:00,HOLX,neutral
624525.0,Hologic Misses Revenue Estimates (HOLX),2010-11-08 16:36:00-05:00,HOLX,negative
624526.0,Hologic Inc. Reports In-Line Results (HOLX),2010-11-08 16:27:00-05:00,HOLX,neutral
624527.0,Hologic Announces Fourth Quarter EPS of $.30,2010-11-08 16:09:00-05:00,HOLX,neutral
624528.0,11 Stocks That Are Breaking Down,2010-11-04 14:34:00-04:00,HOLX,neutral
624529.0,"Top 4 Mid-Cap Stocks In The Medical Appliances & Equipment Industry With The Highest Cash (VAR, HOLX, SNN, EW)",2010-10-21 04:57:00-04:00,HOLX,positive
624530.0,Lowering Estimates On HOLX,2010-10-04 12:21:00-04:00,HOLX,negative
624531.0,Good News for Hologic - Analyst Blog,2010-09-27 15:03:00-04:00,HOLX,positive
624532.0,J.P. Morgan Reiterates Overweight on Hologic (HOLX),2010-09-27 09:09:00-04:00,HOLX,negative
624533.0,Jefferies' Report On Hologic FDA Panel,2010-09-27 07:49:00-04:00,HOLX,neutral
624534.0,Hologic Still Waiting On FDA Panel,2010-09-23 07:57:00-04:00,HOLX,neutral
624535.0,Hologic Waiting On FDA Panel,2010-09-22 06:54:00-04:00,HOLX,neutral
624536.0,CPTS to Enhance Physician Training - Analyst Blog,2010-09-14 17:06:00-04:00,HOLX,neutral
624537.0,"Benzinga's Top Upgrades (CPL, TOT, MRX, HOLX)",2010-09-14 08:22:00-04:00,HOLX,positive
624538.0,Citi Sees Little Upside On Hologic After Meeting With Management (HOLX),2010-09-07 07:36:00-04:00,HOLX,neutral
624539.0,Shorts in Control of Crude  09-23-2010,2010-08-23 14:58:00-04:00,HOLX,negative
624540.0,Hologic Stays Neutral  - Analyst Blog,2010-08-19 12:04:00-04:00,HOLX,neutral
624541.0,Calls Purchased on Hologic (HOLX),2010-08-17 11:24:00-04:00,HOLX,neutral
624542.0,Puts Sold on Hologic Inc. (HOLX) ,2010-08-04 14:42:00-04:00,HOLX,neutral
624543.0,"Benzinga’s Top Pre-Market NASDAQ Gainers (HOLX, FTLK, PCLN, EXPE)",2010-08-04 08:46:00-04:00,HOLX,positive
624544.0,"Hologic Beats, Raises Guidance - Analyst Blog",2010-08-03 14:10:00-04:00,HOLX,neutral
624545.0,Citi Maintains Hold On Hologic (HOLX),2010-08-03 13:54:00-04:00,HOLX,neutral
624546.0,Jefferies Lowers Price Target But Maintains Buy Rating On Hologic (HOLX),2010-08-03 13:20:00-04:00,HOLX,negative
624547.0,Hologic Rises On Upbeat Q3 Earnings,2010-08-03 10:59:00-04:00,HOLX,neutral
624548.0,Piper Jaffray Reiterates Neutral Rating on Hologic (HOLX),2010-08-03 09:39:00-04:00,HOLX,neutral
624549.0,"Benzinga's After Hours Gainers (HOLX, HLF) ",2010-08-02 18:06:00-04:00,HOLX,neutral
624550.0,Hologic Announces Third Quarter Operating Results,2010-08-02 16:36:00-04:00,HOLX,neutral
624551.0,Hologic Beats; Guides Higher (HOLX),2010-08-02 16:26:00-04:00,HOLX,neutral
624552.0,"Top 4 Mid-Cap Stocks In The Medical Appliances And Equipment Industry With The Highest Operating Margin (SNN, VAR, KCI, HOLX)",2010-07-30 05:24:00-04:00,HOLX,positive
624553.0,Calls Purchased on Hologic Inc. (HOLX),2010-07-22 11:10:00-04:00,HOLX,neutral
624554.0,"Benzinga's After Hours Decliners (HOLX, LBTYA, ESI)",2010-07-07 18:19:00-04:00,HOLX,neutral
624555.0,Proposed Acquisition Of Sentinelle Medical To Expand HOLX’s Presence In Breast MRI Segment,2010-07-07 11:41:00-04:00,HOLX,positive
624556.0,J.P. Morgan Reiterates Overweight on Hologic (HOLX),2010-06-10 09:23:00-04:00,HOLX,negative
624557.0,Puts Bought on Hologic Inc (HOLX),2010-06-04 14:19:00-04:00,HOLX,neutral
624558.0,Sellers Packed Up Their Tents  06-03-2010,2010-06-03 18:48:00-04:00,HOLX,neutral
624559.0,Market Waiting On Unemployment Numbers  06-03-2010,2010-06-03 14:27:00-04:00,HOLX,negative
624560.0,Trader Extends Bullish Bet on Hologic (HOLX),2010-06-03 14:17:00-04:00,HOLX,positive
624561.0,HOLX’s Business To Start Showing Recovery Signs,2010-05-27 11:43:00-04:00,HOLX,neutral
624562.0,"Benzinga’s Top Pre-Market Losers (GTXI, TEVA, HOLX, SQQQ, DIOD)",2010-05-27 08:28:00-04:00,HOLX,negative
624563.0,Hologic Unveils New NovaSure Endometrial Ablation System,2010-05-11 10:44:00-04:00,HOLX,neutral
624564.0,HOLX Upgraded To Buy At Craig-Hallum,2010-05-10 09:31:00-04:00,HOLX,neutral
624565.0,"Benzinga’s Top Upgrades (CBR, CKP, MINI, ADCT, HOLX)",2010-05-06 10:00:00-04:00,HOLX,positive
624566.0,J.P. Morgan Raises Price Target On Hologic (HOLX),2010-05-04 13:26:00-04:00,HOLX,neutral
624567.0,Hologic Crushed In After Hours (HOLX),2010-03-18 19:14:00-04:00,HOLX,negative
624568.0,"Benzinga’s Volume Movers (IMAX, GYMB, GEOY, CLNE, HOLX)",2010-03-11 14:25:00-05:00,HOLX,neutral
624569.0,"Hologic, Inc. (HOLX) Shares Surge ",2010-03-11 12:28:00-05:00,HOLX,positive
624570.0,"Unusual Movements Expected In These Shares (ES, GSK, HOLX, USB, WAG)",2010-02-22 09:46:00-05:00,HOLX,positive
624571.0,Hologic (HOLX) Estimates Raised by Morgan Stanley,2010-02-02 23:49:00-05:00,HOLX,neutral
624572.0,"Benzinga’s Volume Movers (HOLX, RCII, BEAV, IDXX, ITMN)",2010-02-02 14:37:00-05:00,HOLX,neutral
624573.0,Hologic Rallying After Earnings (HOLX),2010-02-02 13:45:00-05:00,HOLX,neutral
624574.0,"HOLX Beats F1Q Expectations, Raises Guidance",2010-02-02 13:11:00-05:00,HOLX,neutral
624575.0,SenoRx Inc. (SENO) Not Liable For Patent Infringement,2009-12-24 11:03:00-05:00,HOLX,negative
624576.0,"Opphenheimer Gives A Thumbs Down To Holologic Inc, OPY, HOLX, SI, GE",2009-12-02 13:03:00-05:00,HOLX,neutral
624577.0,"Fast Money Guys  Would Long RIMM, DWA And HOLX And Short FLIR",2009-09-15 13:41:00-04:00,HOLX,neutral
